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ABSTRACT 
In vertebrates, Sox10 is a transcription factor essential for the formation of neural crest 
cells and their derivatives as well as placode-derived inner ear structures. At gastrula 
stages, both presumptive neural crest and placode cells reside at the neural plate border, 
between the non-neural ectoderm and the neural plate. Despite their common site of origin, 
these two cell populations have different characteristics. Neural crest cells are a 
multipotent, stem cell-like population that arises at all axial levels, migrates extensively in 
the embryo and forms a wide array of derivatives ranging from neurons to melanocytes and 
cartilage. On the other hand, placode cells are restricted to the cranial region, have limited 
migratory capacity and contribute only to sensory structures such as the eye, ear, olfactory 
epithelium and distal portions of the cranial sensory ganglia. Interestingly, I have identified 
cis-regulatory modules responsible for the regulation of Sox10 in these two different 
embryonic regions and at different times. Among these modules, I found a downstream 
novel cis-regulatory region, Sox10E2,that mediates initial Sox10 expression in cranial 
neural crest cells and otic placode cells. Through a combination of computational analysis, 
experimental perturbation of putative upstream transcription factors and their binding sites 
within the Sox10E2 regulatory module, plus chromatin immunoprecipitation, I revealed a 
set of direct inputs into Sox10E2 regulatory region. The results show that cMyb, Sox9 and 
Ets1 are responsible for the initial Sox10 expression in delaminating cranial neural crest 
cells, whereas cMyb, Sox8 and Pea3 regulate Sox10 expression in the otic placode. 
Analyzing Sox10 regulation through the enhancer Sox10E2 has helped unravel gene 
regulatory inputs contributing to both neural crest formation and otic placode development. 
vi 
The finding that paralogous factors activate the same regulatory module in these two 
populations suggests the intriguing possibility of an ancient cooption of regulatory function 
and/or a common ancestral crest-placode origin. 
vii 
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Introduction 
 
The neural crest, often referred to as the “fourth germ layer” (Hall 2000), is a 
multipotent stem cell-like population of highly migratory cells that contribute derivatives to 
a wide variety of tissues and organs of the vertebrate embryo. These include but are not 
limited to sensory and autonomic ganglia, adrenal and thyroid glands, smooth muscle of 
major blood vessels, cartilage and bone of the face, and pigmentation of the skin.  As a 
defining feature of vertebrates, neural crest formation has been extensively studied using 
different vertebrate model organisms, ranging from lampreys and fish, to frogs, chicken 
and mouse.  
Neural crest cells form over a long period of developmental time that starts at 
gastrulation and extends into late organogenesis. This process is initiated by a combination 
of inductive signals emanating from neighboring tissues, such as underlying mesoderm or 
adjacent neural and non-neural ectoderm, which set up the presumptive neural crest region. 
As a result, the territory between neural and non-neural ectoderm, termed the neural plate 
border, is competent to respond to signals specifying bona fide progenitors.  The neural 
crest precursors subsequently undergo an epithelial to mesenchymal transition, delaminate 
from the neuroepithelium, and migrate along stereotypical pathways.  After settling in 
various and sometimes distant sites in the embryo, they differentiate into a multitude of 
derivatives.  
In addition to neural crest cells, the unique neural plate border territory also 
contains precursors for dorsal neural tube and cranial placode cells. Fate map analyses 
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demonstrate that the preplacodal territory and presumptive neural crest cells largely overlap 
at the neural plate border (Streit 2007). The preplacodal region contributes to the eye, ear 
and olfactory, epithelium sensory structures. Placodes are defined as thickened ectoderm 
that with the exception of the lens placode, can delaminate from the epithelium and migrate 
into the adjacent mesenchyme in a similar way to neural crest cells (Schlosser 2008). Some 
of the signals and transcription factors involved in the induction of the placodal territory 
will be discussed later in this chapter. 
For over a century, the neural crest and ectodermal placodes have provided a 
productive paradigm for addressing essential questions regarding cell interactions that 
underlay induction, specification and differentiation events during development. In 
particular, the neural crest is the subject of a very extensive literature and descriptive 
database.  In combination with recent genomic cis-regulatory and gene knockdown data, 
this provides a critical mass of information regarding the molecular underpinnings that 
guide neural crest formation.  Such a compelling database calls for a systematic approach 
to integrate diverse information into a multi-step gene regulatory network that describes the 
process of neural crest formation. In contrast, there is comparatively less information 
known about placode development.  However, the otic placode, which is the best studied of 
the ectodermal placodes, has a growing body of molecular information concerning its 
formation and differentiation.   
Accruing molecular information relevant to neural crest induction, specification and 
migration has led to the formulation of a putative vertebrate gene regulatory network 
(GRN) that orchestrates neural crest formation (Meulemans and Bronner-Fraser 2004, 
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Sauka-Spengler and Bronner-Fraser 2008a, Steventon et al. 2005). Because of variation 
between species, the main challenge has been to incorporate the pertinent data, obtained 
from a number of vertebrate developmental models, into a single, pan-vertebrate network. 
In addition to discrepancies in the patterns of gene expression and differences in 
deployment of paralogous genes among various vertebrates  (Meulemans and Bronner-
Fraser 2004), there are also remarkable differences between populations of neural crest 
cells originating from different axial levels within a given species. These include 
differences in mechanisms of delamination and developmental potential, such as the ability 
to generate skeletal structures (Graham et al. 2004). For example, although both cranial and 
trunk crest cells can generate the full repertoire of neural crest cell derivatives (McGonnell 
and Graham 2002), the skeletogenic potential of trunk crest cells is suppressed during 
normal development (Graham et al. 2004). Thus, different neural crest populations may 
well be exposed to at least a subset of unique regulatory interactions.  
Finally, only a limited number of cis-regulatory studies of neural crest genes has 
been reported thus far, making it difficult to discern direct regulatory interactions. The 
majority of known direct regulatory interactions have been elucidated in differentiating 
neural crest derivatives (Sauka-Spengler and Bronner-Fraser 2008a). Thus, the current 
formulation of the neural crest (NC) GRN is largely a consolidation of regulatory 
predictions. Nevertheless, many regulatory steps appear to be highly conserved even in 
basal vertebrate systems (Sauka-Spengler et al. 2007), suggesting that it should be possible 
to assemble a scaffold of regulatory interactions that may be common to all vertebrates and 
may function at all axial levels.   
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In this chapter, I will first introduce the formation of neural crest cells by generating 
an updated representation of the NC-GRN. For this purpose I will attempt to integrate the 
most current neural crest regulatory information and present possible circuit connections 
inferred largely from loss of function analysis together with direct regulatory interactions, 
thus far documented mostly at later stages of differentiation. I will also take into account 
separate spatial subpopulations of neural crest at different levels of the neural axis. As a 
starting point, I will focus on the regulatory state of cranial neural crest cells (Fig. 1, table 
1), which are the first crest population to form and initiate migration in the vertebrate 
embryo. These cells contribute derivatives mainly to the facial skeleton, peripheral nervous 
system and pigmentation in the head.   
To present this updated NC-GRN, I used a generic drawing software Biotapestry 
(http://www.biotapestry.org/), which employs symbolic representation of genes to describe 
their regulatory interactions and integrate experimentally-derived network features 
(Longabaugh et al. 2009).   
Finally, for the otic placode, given that there is limited information regarding gene 
regulatory interactions occurring during placode formation and differentiation, I will focus 
on the current state of knowledge of otic placode development as introduction to 
understanding the gene regulatory connections controlling formation of this ectodermal 
placode. 
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Initial signaling inputs into the neural crest gene regulatory network: BMP, Wnt, FGF 
and Notch pathways in induction and specification 
The classical view suggested that neural crest cell induction occurred during the 
process of neurulation, as the neural folds elevated.  This was thought to occur as a 
consequence of interactions resulting from the juxtaposition of epidermis on elevating 
neural plate (Mancilla and Mayor 1996, Selleck and Bronner-Fraser 1995). However, 
recent findings in frog (Monsoro-Burq et al. 2005) and chicken demonstrate that neural 
crest induction is underway much earlier, during gastrulation (Basch et al. 2006). In 
chicken, for instance, the transcription factor Pax7 is expressed in the neural plate border 
domain where neural crest cells originate, in the mid-gastrula as early as stage HH4+. 
When tissue explants from this Pax7-positive domain of the gastrula were cultured in the 
absence of exogenous inductive signals, they were able to generate neural crest cells (Basch 
et al. 2006), despite the lack of added factors or other tissue interactions. Recent fate maps 
studies show that the neural plate border region is wider and overlaps partially with BMP4-
expressing domain at gastrula stages (Ezin et al. 2009), consistent with the possibility that 
signaling cues are already at play at this place and time.  
Evidence of early specification of neural plate border in frog and chicken has also 
been substantiated by studies in lamprey, where these events are conserved, but happen at a 
much slower rate, making lamprey a suitable system for studying signaling inputs and 
neural plate border specifier readout with much better temporal resolution and therefore in 
much higher detail (Nikitina N. et al. 2008). Interestingly, the induction program and 
resulting expression of transcription factors specifying neural plate border is shared by non-
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vertebrate chordates that do not possess neural crest (Meulemans and Bronner-Fraser 2004, 
Sauka-Spengler and Bronner-Fraser 2008b).  Thus, all the evidence suggests that the neural 
crest cell induction in vertebrate embryos occurs during gastrulation.  However, the early 
inductive events remain unexplored in some species, such as the mouse, highlighting the 
importance of performing comparative analysis in numerous vertebrates. 
The induction of prospective neural crest within the neural plate border is thought to 
occur in response to signaling molecules emanating from adjacent tissues. The “response” 
that sets future neural crest cells apart from other border cells requires the activation of a 
battery of transcription factors that imbues them with multipotency, characteristics of 
proliferating cell, and the competence to respond to later neural crest–specifying signals. 
Identifying the signaling inputs that initiate neural crest induction has been challenging 
since information obtained from different vertebrate systems is sometimes contradictory. 
Fate map studies suggest that presumptive neural crest cells are in proximity to three 
different regions:  presumptive epidermis, neural plate and mesoderm. These tissues are 
thought to secrete signaling ligands, including BMPs, Wnts and FGFs, that have all been 
demonstrated as essential for the early induction, maintenance and differentiation of neural 
crest cells (Knecht and Bronner-Fraser 2002).  Although there are differences between 
neural crest populations at various levels of the neural axis, the inductive signals appear 
similar regardless of axial level. 
Bone morphogenetic proteins (BMPs). In Xenopus embryos, high levels of BMP 
have been shown to be necessary for acquisition of epidermal fate, while inhibition of 
BMPs is required for neural induction (LaBonne and Bronner-Fraser 1998). The neural 
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plate border territory that lies between non-neural ectoderm (future epidermis) and neural 
ectoderm contains neural crest precursors, preplacodal ectoderm, dorsal neural tube and 
epidermis, all of which are exposed to BMP signals. In chicken explant culture 
experiments, juxtaposition of non-neural ectoderm and intermediate neural plate tissue, 
which normally forms only neural tube, can generate neural crest cells.  Addition of BMP4 
and BMP7, endogenously expressed in the non-neural ectoderm, is able to substitute for 
non-neural ectoderm such that neural crest cells are induced from intermediate neural plate 
explants (Liem et al. 1995). It has been proposed that intermediate levels of BMP, obtained 
as a result of diffusion of secreted BMP molecules throughout the ectoderm (BMP 
gradient) are responsible for the induction of neural crest cells. In support of the gradient 
model, zebrafish BMP pathway mutants show either expansion or reduction of the neural 
crest cell domain depending on the alteration of BMP levels (Knecht and Bronner-Fraser 
2002, Nguyen et al. 1998). Alternatively, a gradient that would create the intermediate 
levels of BMP required for neural crest induction may be established by antagonistic 
interactions with cerberus, noggin, chordin, follistatins ligands, secreted by the forming 
neural plate cells, (Sauka-Spengler and Bronner-Fraser 2008a, Tribulo et al. 2003, Wilson 
et al. 1997). Regardless of the way a BMP gradient is established, intermediate levels of 
BMP alone are not sufficient to induce expression of neural crest cell markers in Xenopus 
or any other vertebrate model organisms (Garcia-Castro et al. 2002, LaBonne and Bronner-
Fraser 1998, Wilson et al. 1997). BMP signaling is therefore an important initial step but 
additional signals are required for induction of the neural crest. 
Fibroblast growth factors (FGFs). The FGF family of growth factors represents 
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another set of signaling cues implicated in neural crest induction. In Xenopus animal cap 
assays, FGF2 ligand, together with attenuated BMP signaling, up-regulates expression of 
an early neural crest cell marker, Snail2, whereas over-expression of dominant negative 
FGF receptor blocks Snail2 without affecting neural plate markers (Mayor et al. 1997, 
Villanueva et al. 2002). In Xenopus, over-expression of FGF8, normally expressed in the 
paraxial mesoderm, transiently induces neural crest cells (Monsoro-Burq et al. 2003). 
However, exogenous FGF8 alone is not sufficient to induce the full range of neural crest 
markers (Noden and Trainor 2005). Furthermore the requirement for FGF signaling may 
vary between species, making it difficult to make definitive conclusions about its 
universality. For example, mouse null mutant embryos lacking either FGF or FGFR have 
no obvious defects in neural crest formation (Jones and Trainor 2005). This could be 
explained by functional redundancy of FGF signaling factors. Similarly, in zebrafish, 
neural crest cells develop normally in the absence of mesoderm (Jones and Trainor 2005), 
and mutant embryos carrying mutations in FGF signaling components show no neural crest 
defects. 
Wnt signaling pathway (Wnts). Wnt family members are involved in many aspects 
of neural crest development. Numerous family members, e.g. Wnt6, Wnt7b, Wnt3a, Wnt1 
and Wnt8, are expressed in the right tissue and at the proper time to play a role in induction 
(Knecht and Bronner-Fraser 2002). Wnts are present in the paraxial mesoderm in frog 
(Christian et al. 1991, Knecht and Bronner-Fraser 2002) and in the non-neural ectoderm 
adjacent to the neural folds in chicken embryos (Garcia-Castro et al. 2002). Gain and loss 
of function experiments in frog, chicken and fish have shown that the activation of the Wnt 
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pathway is essential for neural crest cell induction and specification (Garcia-Castro et al. 
2002, LaBonne and Bronner-Fraser 1998, Lewis et al. 2004). For instance, in zebrafish, an 
inducible Wnt inhibitor activated during early neurulation specifically interferes with 
neural crest cell formation without altering the formation of neurons from the central 
nervous system (Lewis et al. 2004). In chicken, Wnt6 is expressed by ectodermal cells at 
the time of neural crest cell induction, and exposing neural plate explants to Wnt6 induces 
the formation of neural crest cells in culture (Garcia-Castro et al. 2002, Schubert et al. 
2002). However, the role of Wnt signaling in induction of the neural crest during 
gastrulation has yet to be examined in the mouse embryo. While Wnt1/Wnt3a double 
mutants exhibit defects in a wide range of neural crest derivatives (cranial skeleton, cranial 
and even dorsal root ganglia as well as melanocytes), it is not yet clear if this results from 
early induction defects, as the analysis of mutant phenotype in the neural plate border has 
yet to be performed (Ikeya et al. 1997). All other gene knock-out experiments used as 
evidence to suggest a role for Wnt signaling in mouse are confined to the lineage 
specification and neural crest cell differentiation rather than early induction. These have 
been performed by targeting the Wnt signaling pathway components in the dorsal neural 
tube (Jones and Trainor 2005), representing a relatively late time point, by which bone fide 
neural crest progenitors reside within the dorsal aspects of neural folds/tube. Thus, it is too 
late to address the role of Wnt signaling in induction events, which have normally taken 
place during gastrulation. In addition, due to gene duplications, and the particularly large 
number of Wnt ligands in mouse genome, it is possible that Wnts act redundantly during 
neural crest cell development in mouse. Their early inductive role may have been missed in 
single Wnt knock-outs, whereas the effects of simultaneous inactivation of several Wnts 
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have not been examined to date (Jones and Trainor 2005). Thus, it remains unclear if Wnt 
signaling pathways play an inductive role at early stages in the mouse embryo. 
 Local cell-cell signals such as Notch/Delta are also found in the vicinity of and/or on  
developing neural crest cells (Endo et al. 2002, Glavic et al. 2004, Williams et al. 1995). In 
chick, Notch is confined to the neural folds together with Hairy2, its direct downstream 
effector, whereas Delta is expressed in the presumptive epidermis (Endo et al. 2002). It has 
been reported that Notch-Delta signaling acts upstream of BMP4 in chick and Xenopus 
embryos and can affect expression of Snail and other neural crest specifier genes (Endo et 
al. 2002, Glavic et al. 2004). However, the function and requirement for Notch during 
neural crest cell development may vary among different vertebrates. In mouse, Delta1 null 
mutants have no apparent early neural crest defects, even though cranial neural crest cells 
express several Notch genes (De Bellard et al. 2002, Williams et al. 1995). It is possible 
that Notch signalling in those cells may be activated by a different ligand. In zebrafish, 
mutants in components of the Notch pathway appear to affect trunk but not cranial neural 
crest (Cornell and Eisen 2005), consistent with the possibility that this signaling pathway 
plays more of a role in trunk than cranial crest, where there may be functional redundancy 
with other signaling pathways. 
Despite some species specific differences, it is generally agreed that a combination 
of inductive signals activates a battery of immediate downstream genes in the neural plate 
border that give the cells the capacity to become neural crest cells. For instance, the 
combination of low levels of BMP plus Wnt family members can induce expression of 
Snail2 and other neural crest genes in Xenopus explants (LaBonne and Bronner-Fraser 
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1998) 
 
Neural Plate Border Specifiers  
Signaling inputs into the neural plate border territory activate a battery of 
transcription factors whose collective expression sets presumptive neural crest cells apart 
from other border progenitors by conferring to them the competence to respond to neural 
crest specifying signals. These genes, termed neural plate border specifiers, appear early 
during neurulation and include homeobox transcription factors Mxs1/2, Dlx5, Pax3/7 and 
Gbx2, as well as zinc finger-containing Zic proteins. Although little is known about direct 
inputs that regulate their expression or about regulatory interactions that occur among 
them, gain- and loss-of-function experiments suggest possible hierarchical 
interrelationships.  Understanding their regulatory interrelationships helps expand links 
within the gene regulatory network (GRN), adds a number of testable hypotheses, and can 
serve as an experimental guide. 
In Xenopus, integration of inputs from BMP, FGF, Wnt and Notch signaling 
pathways activates expression of Msx1 (Monsoro-Burq et al. 2005, Tribulo et al. 2003).  
Zic1 and Pax3 are also downstream of Wnt, BMP and FGF signals (Sato et al. 2005), while 
FGF8 can experimentally induce Zic5 expression, but is not required to do so endogenously 
(Monsoro-Burq et al. 2003). While BMP and FGF signals can regulate individual 
expression of Zic1 and Pax3, both transcription factors need to be simultaneously activated 
to achieve neural crest specification. In Xenopus embryos, high levels of either 
transcription factor alone (Pax3 or Zic1) promotes alternative neural plate border fates 
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(hatching gland or pre-placodal progenitors, respectively) (Hong and Saint-Jeannet 2007). 
Furthermore, FGF8 and Wnt signals act in parallel at the neural plate border and seem to 
independently converge onto Pax3 (Monsoro-Burq et al. 2005). Hairy2, a direct 
downstream effector of Delta/Notch input into the neural plate border territory, also 
participates in regulation of neural crest specifier genes (Glavic et al. 2004). Dlx5, 
regulated by attenuated levels of BMP (Luo et al. 2001), expands Msx1 expression domain 
upon ectopic activity (Woda et al. 2003).  
Since neural plate border specifiers are the first transcription factors to appear at the 
border, it is not surprising that they may be directly activated by simultaneous input of 
multiple signaling pathways. Although evidence for direct interactions is sparse, Brugger 
and colleagues show direct conversion of the intermediate levels of BMP signal onto the 
Msx2 promoter (Brugger et al. 2004). Recently, Li and colleagues found that Gbx2, a gene 
essential for the anteroposterior partitioning of the neural folds, is expressed in an 
ectodermal region that includes the future neural plate border from which crest cells will 
arise (Li et al. 2009). The authors demonstrated that Gbx2 is an immediate direct 
downstream target of Wnt signaling. Furthermore, epistatic rescue experiments reveal that 
Gbx2 is positioned upstream of the earliest previously reported neural plate border 
specifiers, Msx1 and Pax3.  These results suggest Gbx2 as a candidate for mediating the 
earliest Wnt inductive signaling input into NC GRN. 
Studying the hierarchical interrelationships between newly activated neural plate 
border specifiers is challenging due to the inaccessibility and/or rapidity of the induction 
and border specification processes in most vertebrate models.  Due to their slow 
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development, however, lamprey embryos allow unprecedented temporal resolution of 
neural plate border specification.  This has enabled chronological ordering of the onset of 
gene expression amongst neural plate border specifiers, as well as gene perturbation assays 
to establish their hierarchical relationships. The study by Nikitina and colleagues 
establishes Msx, but also the neural crest specifier AP-2a, at the top of the neural plate 
border cascade, with many of the factors present at the border (both known border 
specifiers such as Msx, Pax3/7 or Zic, as well as early crest specifiers, such as AP-2a, n-
Myc or Id) feeding back and regulating each other’s expression (Nikitina N. et al. 2008). It 
will be interesting to further investigate direct regulatory relationships at the border as well 
as test similar interactions in higher vertebrates, such as chick embryo, which also have 
good temporal resolution of neural plate border specification. 
 
Neural crest specifier genes  
 The regulatory state during neural crest specification is defined by the cumulative 
expression of a set of genes, termed neural crest specifiers, in the premigratory and early 
migrating bona fide neural crest progenitors. Some neural crest specifiers persist in the 
migrating and differentiating neural crest (such as Sox10), while others such as Snail2 are 
only present at the onset of the specification process and epithelial to mesenchymal 
transition prior to their emigration. Some neural crest specifiers have a biphasic expression 
pattern, first being present in neural crest progenitors and again later in differentiating 
derivatives (e.g. Sox9). A subgroup of transcription factors such as AP-2a, Snail1/2, Id, c-
Myc and Twist are expressed even before neural crest progenitors become apparent, though 
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the timing of their onset and presence within the neural plate border varies among different 
vertebrates.  In a basal vertebrate, the lamprey, expression of this subgroup of early-
expressing neural crest specifiers begins at the early neurula stage, preceding expression of 
canonical neural crest markers such as Sox10 and FoxD3 (Nikitina N. V. and Bronner-
Fraser 2009, Sauka-Spengler et al. 2007). This raises the intriguing possibility these genes 
may function as a key regulatory link between establishing competence in presumptive 
crest at the neural plate border and specification of bona fide neural crest cells. During 
specification, neural crest specifier genes are either directly or indirectly regulated by 
neural plate border genes. They also receive signaling pathways inputs, and undergo 
intricate cross-regulatory activity with other neural crest specifiers.  
 The regulatory control of Snail2 exemplifies how signaling pathways and regulatory 
factors merge to direct the expression of a key gene involved in the epithelial to 
mesenchymal transition of neural crest cells. Cis-regulatory analysis shows that Snail2 is 
directly regulated by intermediate levels of BMP and modulated by Wnt pathway input.  
Accordingly, the Snail2 regulatory region contains binding motifs for Smad1, a 
transcription factor that mediates BMP signaling input (Sakai et al. 2005) and Tcf/Lef1, 
mediating b-catenin-dependent Wnt signal (Vallin et al. 2001). Furthermore, in Xenopus 
animal cap explants, a combination of the BMP inhibitor chordin and Wnt8 is sufficient to 
induce the expression of Snail2 as well as Id3, helix-loop-helix transcriptional regulator 
involved in specification of neural crest (Kee and Bronner-Fraser 2005). Over-expression 
of Hairy2, a direct downstream effector gene of Notch signaling causes an expansion of 
Snail2 expression in Xenopus (Glavic et al. 2004) and has been proposed as a direct input 
16 
 
into the Snail2 regulatory region. Finally, it has been demonstrated that the neural plate 
border specifiers, Zic1, Msx1 and Pax3/7, are independently necessary and sufficient for 
the expression of a group of neural crest cell specifiers including Snail2 (Meulemans and 
Bronner-Fraser 2004, Sato et al. 2005, Tribulo et al. 2003). This suggests that regulatory 
signaling inputs activating Snail may be mediated by neural plate border specifiers, such as 
Zic1, Mxs1 and Pax3/7. Conversely, signaling inputs can act in parallel with upstream 
border specifiers to control neural crest specifiers expression. For instance, in Xenopus 
embryos, b-catenin-dependent canonical Wnt signals cooperate with Zic1 and Pax3/7 to 
activate Snail2 expression (Sato et al. 2005).  
Far less is known about the regulation of other neural crest specifiers. Twist, for 
instance, is ectopically activated upon Snail2 and FoxD3 misexpression in Xenopus 
embryos and ectodermal explants, perhaps indirectly via  Zic (Meulemans and Bronner-
Fraser 2004, Sasai et al. 2001). In contrast, expression of a constitutively activated 
truncated version of a Notch receptor in Xenopus embryos down-regulates Twist 
expression, simultaneously causing the neural plate to expand and the epidermis to regress. 
Thus, it is not clear if the loss of Twist expression is a result of regulatory changes caused 
by a shift in signaling or a secondary effect due to neural plate expansion at the expense of 
neural crest (Coffman et al. 1993, Cornell and Eisen 2005). Although it is intriguing to 
speculate that Notch-Twist regulation is mediated by Zic1, there is currently no data either 
supporting or refuting this possibility. Some early neural crest cell specifiers, such as Id and 
cMyc, appear to function within the neural crest gene regulatory network to maintain the 
neural crest cells in a multipotent state, mediating critical cell cycle and/or cell fate 
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decisions (Bellmeyer et al. 2003, Kee and Bronner-Fraser 2005, Light et al. 2005). Id is a 
transcriptional repressor that possesses a helix-loop-helix (HLH) domain for dimerization, 
but lacks a basic domain for DNA binding. Id proteins interfere with gene expression by 
binding to transcriptional activators from bHLH families and preventing them from 
activating their direct targets.  In lamprey, initial expression of Id at the neural plate border 
precedes that of cMyc (Nikitina N. V. and Bronner-Fraser 2009). However, in Xenopus 
embryos cMyc can directly regulate Id expression (Light et al. 2005) indicating that other 
factors, such as AP-2a or Zic1, may be responsible for the initial expression of Id (Nikitina 
N. et al. 2008). Therefore, cMyc functions directly upstream of Id, via the identified cis-
regulatory region, to maintain its expression in the premigratory neural crest cells.  
 By the time premigratory and delaminating neural crest cells express transcription 
factors such as FoxD3, Sox9, Snail2 or Sox10, they are specified to a neural crest fate.  The 
winged-helix transcription factor FoxD3 appears to pay a role in maintaining neural crest 
multipotency by preventing early differentiation (Lister et al. 2006). Direct regulatory 
inputs responsible for FoxD3 activation and maintenance in the pre-migratory and later 
migrating neural crest cells have yet to be described. Similar to Snail2 activation, there is 
evidence from studies in Xenopus embryos suggesting that a Hairy2 mediated Notch signal 
regulates FoxD3 (Wettstein et al. 1997).  In addition, the collective activity of Zic1 and 
Pax3/7 complemented with Wnt input induces FoxD3 expression (Sato et al. 2005). Gain 
and loss of function experiments in Xenopus have also shown that Msx1 regulates the 
expression of FoxD3 (Tribulo et al. 2003).  
 The SoxE family of transcription factors, most notably Sox9 and Sox10, have well-
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established roles in neural crest development.  In Xenopus, Sox9 expression has been 
shown to be dependent on activity of AP-2a (Lee H. Y. et al. 2004a, Luo et al. 2003, Saint-
Germain et al. 2004).   Moreover, AP-2a binding motifs have been identified within early-
acting Sox9 cis-regulatory region in mouse, using in silico database searches (Bagheri-Fam 
et al. 2006). In Xenopus Gbx2 together with Zic1 can induce the expression of neural crest 
specifiers genes including Sox9 and Snail2 while inhibiting pre-placodal fate (Li et al. 
2009). However, the direct regulatory inputs into Sox9 have yet to be experimentally 
demonstrated. In addition to the neural crest, SoxE genes are also expressed in the 
developing ear.  However, far less is known about their roles during otic placode 
development. 
Using comparative bioinformatics and in ovo electroporation of reporter plasmid 
constructs carrying candidate Sox10 regulatory fragments, I identified the earliest acting 
Sox10 cis-regulatory region, referred to as Sox10E2, which is downstream of the coding 
region. Recently through extensive characterization of this initial Sox10-activating cis-
regulatory element in chicken embryo (Betancur et al. 2010), I demonstrated that the 
synergistic activity of cMyb, Sox9 and Ets1 directly and specifically regulate the onset of 
Sox10 in the cranial neural crest via this Sox10 enhancer, while another combination of 
factors, including cMyb, Sox8 and Pea3 regulates Sox10 expression through this same 
enhancer in the otic placode.  Since cMyb participates in the regulation of Sox10 in both 
placode and neural crest cells, it appears to have a conserved regulatory role on the  
initiation of Sox10 expression. The possible role of the proto-oncogene cMyb in neural 
crest cells development was first suggested in migrating trunk neural crest cells, where the 
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knockdown of cMyb reduced Snail2 expression (Karafiat et al. 2005). However cMyb 
expression in chicken begins much earlier, at gastrula stage. It becomes confined to the 
neural folds as the neural plate begins to invaginate and later continues to be expressed in 
migrating crest cells (Betancur et al. 2010). By morpholino, I demonstrated that the knock 
down of cMyb in the cranial neural crest causes a diminution of Sox10 expression, 
confirming that this factor acts upstream of Sox10.  Ets1 expression is specific to the 
cranial crest population, and first appears in neural crest progenitors in chicken embryos as 
the neural folds are closing (Theveneau et al. 2007). Trunk neural crest cells, which 
normally do not express Ets1, arrest in the G1 phase of the cell cycle prior to separating 
from neuroepithelium and synchronously enter the S phase upon delamination. Interfering 
with G1/S transition prevents the delamination process (Burstyn-Cohen and Kalcheim 
2002). Ectopic expression of Ets1 in the trunk region promotes massive emigration 
independent of cell cycle (Sauka-Spengler and Bronner-Fraser 2008a, Theveneau et al. 
2007), more like migration in the cranial region. All this data together with the finding that 
Ets1 directly regulates Sox10 specifically in cranial crest cells, raises the intriguing 
possibility that Ets1 may have a unique function in the cranial neural crest of establishing a 
regulatory state that activates cranial crest specific effector genes responsible for the pre-
migratory to migratory transition. The differential expression of Ets1 and its regulatory 
relationship to other neural crest genes highlights interesting differences between neural 
crest populations at different levels of the neural axis. 
Neural crest cell specifiers, in general, represent a “node point” onto which 
inductive inputs mediated by or acting in parallel with neural plate border specifiers 
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converge. Those specifying transcription factors in turn control the expression of effector 
genes that will give neural crest cells their unique migratory and multipotent 
characteristics. Therefore, in the life cycle of a neural crest cell, it is critical to keep the 
specifier genes running as a unit in the network. For this purpose in frog, there seems to 
exist high interdependence among neural crest cell specifiers. Gain and loss of function 
experiments suggest that Snail2 regulates FoxD3, Twist and Sox10 expression, probably in 
an indirect fashion (Aoki et al. 2003, Aybar et al. 2003). Ectopic expression of AP-2a in the 
neural plate activates the ectopic expression of Snail2 (Spokony et al. 2002), while Sox10 
feeds back to maintain Snail2, Sox9 and FoxD3 expression (Honore et al. 2003). However, 
in mouse and zebrafish, there is less tight cross-regulation among neural crest cell 
specifiers since knockouts of Snail1 and Snail2, Sox10 and AP-2a have effects later, during 
differentiation in selective neural crest derivatives rather than at this state of specification 
(Meulemans and Bronner-Fraser 2004). Perhaps in other organisms, neural crest specifier 
genes have a more redundant function during specification, and their function becomes 
more restricted as the neural crest advance to the differentiating state. Conversely, this 
discrepancy may be due to the higher rate of gene duplication and functional compensation 
by redundant paralogs (Lister et al. 1999, Luo et al. 2001, Yan et al. 2005). Only through 
characterization of cis-regulatory modules will we be able to understand the degree of 
importance of these cross-regulatory events  of neural crest cell specifiers. 
 
Genes regulating neural crest emigration and migration 
 To initiate migration, premigratory neural crest cells must delaminate from the 
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neuroepithelium. Thus, transcription factors acting on the neural crest precursor pool must 
not only maintain them in a multipotent and proliferating state, but also activate or repress 
effector genes involved in their epithelial to mesenchymal transition (EMT). To allow cells 
to become less compact and acquire motility, EMT induces changes at the cellular level 
that include switches in cell junctions and adhesion properties and major cytoskeletal 
rearrangements.  One characteristic of the EMT process includes a switch in cadherin 
expression, with up-regulation of type II cadherins, that allow for less adhesiveness and 
concomitant down-regulation of type I cadherins and other factors characteristic of 
epithelial cell types. In trunk neural crest cells in the chick, forced expression of FoxD3 
down-regulates N-cadherin (Type I cadherin) while concomitantly up-regulating 
expression of Cad-7, a type II cadherin, and b1 integrin (Cheung et al. 2005). Since FoxD3 
is a repressor, the latter effect is likely to be indirect.  Confirming a role of FoxD3 during 
delamination, mis-expression of FoxD3 along the entire dorsoventral axis of chicken neural 
tube caused an increase in expression of neural crest cell markers, including Cad-7, and 
promoted delamination and migration from more ventral regions of the neural tube while 
simultaneously repressing interneuron differentiation (Dottori et al. 2001).  Normally, Cad-
7 is only expressed in migrating crest cells and excluded from neural tube (Nakagawa and 
Takeichi 1995). Similar to FoxD3, Sox10 over-expression induces b1 integrin expression 
while inhibiting N-Cad expression (Cheung et al. 2005). Although it is difficult to ascribe 
direct gene regulatory interactions, it is clear that both FoxD3 and Sox10 affect expression 
of EMT effector genes, such as cadherins, whose orchestrated regulation is crucial for EMT 
to occur.  
22 
 
 Snail1 and Snail2 genes have a clear role in controlling cell adhesiveness and many 
other aspects of epithelial to mesenchymal transitions in embryonic and metastatic cells 
(Thiery and Sleeman 2006). Snail1 is directly responsible for the negative regulation of E-
cadherin, a cell adhesion molecule characteristic of epithelial cells (Cano et al. 2000). 
Similarly, Snail2 acts directly to negatively regulate the expression of Cadherin 6B, a 
molecule that characterizes cell-cell adhesion amongst dorsal neural tube cells, most of 
which are premigratory neural crest progenitors (Taneyhill et al. 2007). Sox5, a member of 
the SoxD family, is another transcription factor proposed to have a regulative role during 
neural crest cell delamination. Sox5 mis-expression causes an increase in the number of 
cranial neural crest cells generated.  Sox5 up-regulates Snail2, FoxD3, and Sox10 
transcription factors in migrating crest cells and RhoB, a member of the Rho family of 
small GTPases that controls a variety of signal transduction pathways (Perez-Alcala et al. 
2004). RhoB is a well-known regulator of events that change cell morphology, such as the 
actin cytoskeleton rearrangements, the formation of focal adhesions and stress fibers (Liu J. 
P. and Jessell 1998).  All these cellular changes are necessary for neural crest delamination 
(Nobes and Hall 1995). The function of RhoB in cranial crest cells appears to be distinct 
from that in the trunk where it acts as a negative modulator, down-regulating N-cadherin 
and preparing cells for delamination (Groysman et al. 2008). Again, cis-regulatory 
profiling will confirm if the sub-circuit initiated by Sox5 consists of direct feeding onto 
Snail, FoxD3, Sox10 and RhoB regulatory modules in delaminating cranial crest cells. In 
other studies it has been demonstrated that Sox5 can bind to cis-regulatory modules via 
known motifs, previously identified as Sox9 and Sox10 binding sites, and can modulate 
expression of downstream target genes by recruiting specific co-factors during neural crest 
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cell differentiation (Hattori et al. 2008, Stolt et al. 2008). It is likely that the same 
regulatory mechanism is used during cranial crest delamination.  Since Sox5 appears early 
in the premigratory neural crest, it may be also be involved in the regulatory interactions 
that take place during neural crest specification. However, this possibility remains to be 
explored. 
 Most of the transcription factors that are involved in neural crest cell specification 
continue to be expressed in neural crest cells as they migrate. However, other unidentified 
upstream inputs, different from those that initiate expression of the neural crest specifiers in 
the pre-migratory state, may be responsible for maintaining their expression during 
migration. Moreover, different upstream regulators may be characteristic of neural crest 
cells with various differentiation potential, correlated with their future fate. For example, 
inactivation of Wnt signaling input sites within the Sox9 enhancer decreased reporter 
expression exclusively in neural crest cells migrating into the first but not second or third 
branchial arches (Bagheri-Fam et al. 2006). Cis-regulatory analysis in mouse has shown 
that during neural crest migration, Sox10 is directly regulated by Pax3, AP-2 and Sox9, but 
also receives Wnt signaling input (Werner et al. 2007).  Analysis in zebrafish confirms that 
a Wnt signal feeds directly onto the Sox10 regulatory element during migration, but also 
strongly suggests SoxE, NFkB as well as Notch signals as potential direct Sox10 regulatory 
inputs (Dutton J. R. et al. 2008). These studies also demonstrated that there is no direct 
regulatory interaction between FoxD3 and Sox10, despite the presence of FoxD3 binding 
motifs in Sox10 cis-regulatory regions. However, FoxD3 has been reported as a negative 
regulator of Sox10 (Pohl and Knochel 2001, Sasai et al. 2001).  It is plausible that the 
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negative feed of FoxD3 repressor on Sox10 regulatory module may have been missed 
because assays employed to identify direct regulators are more targeted to isolation of 
positive regulatory influences (activators). Conversely, FoxD3 may function as regulator of 
Sox10 activity via yet unidentified enhancers. Alternatively, the loss of Sox10 expression 
after FoxD3 inactivation may suggest that their functional interactions are not direct and 
perhaps involves an intermediary inhibitor.  
 Prior to and during neural crest migration, cells acquire signaling receptors that allow 
them to interact with their environment and help guide them along specific pathways. Such 
molecules include Neuropilin-1/2, Robo-1/2 and Ephrin receptors among others in the 
cranial region (Sauka-Spengler and Bronner-Fraser 2008a). However, the transcription 
factors that regulate expression of these signaling molecules remain elusive. Similarly, 
there is not much information regarding the upstream regulators of genes that are involved 
in cell cycle decisions prior to cranial neural crest cell delamination; only a few regulatory 
interactions that prevent cells from undergoing apoptosis have been described. In Sox9 null 
mice, neural crest cells undergo massive apoptosis (Cheung et al. 2005). Similarly, 
zebrafish neural crest cells lacking Sox9 within the branchial arches show a predominant 
cell death phenotype (Yan et al. 2005).  Gain and loss of function experiments in Xenopus 
suggest a direct regulatory connection between Sox9 and another anti-apoptotic factor, 
Snail1 (Aoki et al. 2003). 
 In summary, the combined regulatory function of neural crest specifier genes and 
their downstream effectors endows neural crest cells with the characteristics rendering 
them mesenchymal, proliferative and motile. However, out of a very large number of 
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neural crest downstream effector genes, there is only a scarce number whose direct 
regulatory inputs and links to upstream neural crest specifiers is known, making it difficult 
to ascribe their precise positions within the neural crest gene regulatory network.   
 
The transition from migration to differentiation 
How neural crest cells lose their migratory and multipotent characteristics as they 
prepare to differentiate remains an open question.  It is logical to postulate that a separate 
set of gene batteries is deployed in each neural crest lineage. Cis-regulatory analysis 
combined with functional and binding affinity assays, have revealed several sub-circuits of 
direct gene regulatory interactions for each lineage. After neural crest cells have migrated 
and reached their final destinations, typically expression of most early neural crest cell 
specifiers, including Snail/Snail2, FoxD3, Id and AP-2, is down-regulated, although the 
direct regulatory interactions triggering this down-regulation are elusive (Meulemans and 
Bronner-Fraser 2004). Nevertheless, there is some evidence to suggest that FoxD3 
participates in repression of Snail1b (previously Snail2) in zebrafish. Its absence causes 
prolonged expression of Snail1b when it would normally be turned off (Lister et al. 2006). 
Exogenous expression of FoxD3 in Xenopus causes repression of endogenous FoxD3 
indicating that FoxD3 can directly down-regulate its own expression in a negative 
autoregulatory loop (Pohl and Knochel 2001). Down-regulation of FoxD3 in migrating 
cells prior to differentiation does not take place in all neural crest derived lineages. While 
absent from melanoblasts, FoxD3 expression persists in neural/glial precursors, where it 
prevents Pax3 from binding to the promoter of Microphtalmia-associated transcription 
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factor (MITF) and thus protects sensory precursors from assuming a pigment cell fate 
(Thomas and Erickson 2009). These data demonstrate the importance of negative 
regulation in acquisition of cell fate in cell types with multiple developmental potentials, 
like the neural crest.  It will be essential to study differential upstream inputs that confine 
FoxD3 or other possible repressive circuits that act as regulatory switches between different 
lineages.  
Notable exceptions are SoxE transcription factor family members, Sox9 and Sox10, 
which persist in specific subpopulations of neural crest cell derivatives and appear to be 
master regulators of terminal differentiation in the majority of neural crest derivatives 
(Kelsh 2006, Sauka-Spengler and Bronner-Fraser 2008b). The necessity of different SoxE 
genes for specification of distinct neural crest sublineages has recently been demonstrated 
in zebrafish (Arduini et al. 2009). Sox9 and Sox10 are maintained in cartilage and 
neuron/glial/melanocyte lineages, respectively, such that Sox10 persists in melanoblasts 
and elements of peripheral nervous system, while Sox9 is characteristic of neural crest-
derived chondrocytes. Experiments in Xenopus suggest that the HLH transcriptional 
repressor Id prevents premature neural crest cell differentiation during neural crest 
migration. Constitutive expression of Id family members in migrating neural crest cells 
populating the pharyngeal arches, most of which would normally adopt a cartilage fate, 
extends Sox10 expression which is normally downregulated in this population when they 
enter the arches (Light et al. 2005).Furthermore, over-expression of Id3 in melanocytes or 
neural crest-derived cartilage cells, independently affects differentiation of these two cell 
lineages (Light et al. 2005). Thus, downregulation of Id is necessary for occurrence of the 
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initial steps of neural crest cell differentiation. It is plausible that endogenous down-
regulation of Id indirectly releases inhibitors that feed into the neural crest specifier 
module, while the maintainance of Sox9 in cartilage and Sox10 expression in melanocyte 
derivatives, may be independent of the Id regulatory cascade. Alternatively, there is strong 
evidence indicating that Id helps establish the time window during which cells respond to 
differentiating signals (Light et al. 2005). At the proper time, it may release activator genes 
involved in differentiation and maintenance of Sox9 and Sox10 expression in their 
respective differentiated lineages.  
Another possibility is that the inhibitory activity of Id maintains Sox10 and perhaps 
Sox9 expression at low levels. It has been suggested that low concentrations of Sox10 
sustain the multipotency of neural crest cells and at higher levels inhibit neuronal 
differentiation and promotes glia and melanoblast formation (Kim et al. 2003, Paratore et 
al. 2001). Resolving regulatory interactions to the detail that would allow unraveling of 
these complex events remains a challenge.  The battery of genes involved in maintaining 
neural crest cells may change such that new regulatory interactions emerge, some involving 
redeployment of transcription factors involved in early neural crest cell specification to 
perform a later function in cell differentiation. For example, the way that Sox9 and Sox10 
acquire new instructive role for directing the fate of certain neural crest derivatives may 
involve acquisition of new cofactors. 
 
Differentiation of the cranial neural crest 
Neural crest cells give rise to a widely varied of derivatives ranging from 
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melanocytes, glia, neurons, to skeletal components of the head. In general, the type of 
derivative depends upon the axial level from which the neural crest originate and the time 
of their emigration from the neuroepithelium. For example, midbrain and rhombomere (r) 1 
and r2 neural crest contribute to neurons and glia of the trigeminal ganglion as well as the 
skeleton of the upper and lower jaw. Neural crest cells from r4 give rise to neurons of the 
proximal facial ganglion and the hyoid bone. Neurons of the proximal and jugular ganglia 
and skeletal components of the post-pharyngeal arches are derived from post otic neural 
crest streams r6 and r7 (Graham et al. 2004, Lumsden et al. 1991, Schilling and Kimmel 
1994). Vagal neural crest forms enteric nervous system as well as cardiac and aortic arch 
components.  Trunk neural crest forms sensory and autonomic ganglia and the adrenal 
medulla.  
The time of migration also influences the types of derivatives that neural crest cells 
form. Early migrating cranial neural crest cells populate the pharyngeal arches to generate 
bone, cartilage and connective tissue (skeletal structures) while the later wave stays close to 
central nervous system and generates neurons and glia of the cranial ganglia (Graham et al. 
2004). Melanocytes are derived from neural crest from all axial levels. In mouse, a 
subpopulation of neural crest cells within a dorsomedial domain of the neural tube at the 
midbrain-hindbrain junction migrate exclusively into the developing dermis and express 
melanocyte lineage markers (Trainor 2005).  
Of all the cranial neural crest derivatives, melanocytes and chondrocytes are the 
two lineages in which the most cis-regulatory work has been performed, allowing 
predictions regarding regulatory subcircuits. In melanocytes, Sox10, in synergy with Pax3, 
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directly regulates Mitf by binding to a proximal region of its promoter (Bondurand et al. 
2001, Verastegui et al. 2000). Then, in collaboration with Mitf, Sox10 directly regulates 
expression of an enzyme necessary for melanin synthesis, dopachrome tautomerase 
(Dct/TRP2) (Ludwig et al. 2004).  
Sox5 also plays a direct modulatory role in melanocyte differentiation. Sox5 and 
members of the SoxD family of transcription factors are characterized by their lack of a 
transactivation domain (Lefebvre et al. 1998). It has been speculated that they regulate 
transcription by recruiting other co-activators or co-repressors to regulatory regions. In 
melanocytes, Sox5 binds to the Mitf and Dct/TRP2 promoter regions through Sox10 
identified binding elements. It recruits the co-repressors CtBP2 and HDAC to compete 
with Sox10 for binding of these regulatory regions, therefore modulating Sox10 inducing 
activity (Stolt et al. 2008). During chondrocyte development, on the other hand, Sox9 
directly regulates expression of important cartilage markers such as Col2a1 (Lefebvre et al. 
1997), Col11a2 (Bridgewater et al. 1998), and CD RAP (Xie et al. 1999) by binding to 
sites in identified enhancer regions. Interestingly, Sox5 null mice have skeletal defects and 
particularly craniofacial defects (Smits et al. 2001). This suggests another role for Sox5, in 
chondrocyte development. Consistent with this possibility, it was recently found that Sox5 
cooperates with Sox9 and other co-factor in chondrocytes to regulate expression of Col2a1 
by binding to Sox9 target sites (Hattori et al. 2008). These inputs at the effector level of the 
neural crest gene regulatory network are a few notable examples how precise gene 
regulatory subcircuits can guide neural crest subpopulation to differentiate into specific 
derivatives.  
30 
 
For specification and differentiation of cranial neural crest cells into glia and 
neurons, there is little known about direct regulatory interactions. Most of knowledge about 
direct regulatory interactions in neurogenic neural crest derivatives comes from 
experiments performed in the trunk neural crest cells. These studies show that 
differentiation into neural crest-derived neurons and glia requires re-deployment of factors 
utilized earlier, during neural crest induction and specification. As an example, Notch and 
Delta proteins are expressed in neural crest cells that populate the presumptive trigeminal 
ganglion region, where they undergo gliogenesis and neurogenesis. The Notch signaling 
pathway promotes gliogenic differentiation while inhibiting neuronal differentiation 
(Nakamura et al. 2000, Ohtsuka et al. 1999). Furthermore, the cell fate decision between 
gliogenic and skeletogenic differentiation appears to be controlled in part by the use of 
different mediators of Notch signaling. While the Deltex-mediated Notch pathway controls 
gliogenesis, simultaneous activation of the RBP-J and the Deltex-dependent Notch 
pathways leads to chondrogenic specification (Ijuin et al. 2008), mediated by previously 
characterized Notch downstream effectors, Hes1 and Hes5 (Jarriault et al. 1995). The 
downstream readouts used to differentiate the gliogenic and chondrogenic lineages were 
glial fibrillary acidic protein (GFAP) and Collagen type II a (Col2a), respectively. Thus, 
the above-mentioned studies place these specific markers as potential effectors genes, 
acting directly downstream of Notch signaling inputs mediated by Hes1 and Hes5 factors 
(Ijuin et al. 2008).  
In addition to its role in melanocyte differentiation, Sox10 also controls 
specification of glial and neuronal fates in neural crest derivatives specification. Sox10 
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appears to further participate in the differentiation of glia, as its expression within this 
lineage persists into terminal differentiation stages (Kelsh 2006). During glial 
differentiation, Sox10 directly regulates the expression of protein zero (P0) (Peirano et al. 
2000), myelin basic protein (MBP), peripheral myelin protein 22 (PMP22) and the gap 
junction protein connexin 32 (Cx32), thus affecting all major components of the 
myelination process (Bondurand et al. 2001). Finally, evidence concerning the direct 
regulatory role of Sox10 during differentiation of neural crest-derived neurons comes from 
studies of sensory and autonomic lineages in the trunk. In mouse neural crest cultures, 
Sox10 regulates the expression of mouse achaete-scute homologue 1 (MASH1) and the 
paired homeodomain (Phox2b), transcription factors that are essential for autonomic 
neurogenesis (Kim et al. 2003). Sensory neurons derived from the dorsal root ganglia 
transiently express Sox10, shown to regulate the expression of proneural gene neurogenin 1 
in zebrafish (Carney et al. 2006). It is possible that similar interactions, involving direct 
Sox10 regulatory inputs and expression of the sensory neuronal marker Neurogenin1, take 
places during cranial neurogenesis.  
Finally, it is important to stress the role of negative regulation during steps of 
terminal differentiation into neural crest derivatives. The recent study by Sun and 
colleagues, shows that LIM-homeodomain factor Islet1 specifically regulates subprograms 
within different sensory neuron lineages (Sun et al. 2008). Islet1 is specifically required to 
repress/terminate gene expression at the end of the neurogenic phase of development, such 
as Neurogenin1 or NeuroD family members. Interestingly, Islet1 is also required to repress 
a number of transcription factors not normally expressed in the sensory ganglia, but found 
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in the spinal cord and hindbrain, such as LIM-homeobox factors Lhx1 and Lhx2 and 
oligodendrocyte markers Olig1 and Olig2. This suggests that Islet1 inhibition also serves as 
a control switch, keeping the cells within the sensory lineage (Sun et al. 2008). 
 
Ectodermal placodes also arise at the neural plate border 
For otic placode development, regulatory information and particularly cis-
regulatory analysis are limited and a GRN has yet to be assembled. Nevertheless, a 
compilation of data suggests that ectodermal cells at the neural plate border first acquire a 
“preplacodal state” (Schlosser 2008, Streit 2007), characterized by expression of a set of 
transcription factors in a common preplacodal domain from which all placode precursors 
emerge. These are subsequently maintained in all placodes and lost from non-placodal 
ectoderm. Among the specific placodal transcription factors identified so far, are members 
of the Six and Eya families. These factors have been implicated in multiple processes 
during placode formation and the requirement of these genes for normal placode 
derivatives development has been extensively studied. For instance, mice heterozygous in 
Eya1, display a phenotype similar to an inherited form of deafness in humans, the 
branchio-otorenal (BOR) syndrome (Abdelhak et al. 1997, Xu et al. 1999). Eya1 null mice 
have severe inner ear defects characterized by the arrest of otic formation at early stages. 
Mutations in Six1 also cause similar defects to those observed in the human syndrome 
BOR. Furthermore, in the otic vesicle loss of Eya1 and Six1 lead to reduced proliferation 
(Bonini et al. 1993). Thus, the importance of Six and Eya family members together with 
their specific early placodal expression have made these factors good candidates for 
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defining the placode territory at early developmental stages (Streit 2007).  
However, these factors are not the only presumptive preplacodal factors.  There are 
a number of factors that are found in a wide domain which encompasses neighboring 
preplacodal territories such as the non-neural ectoderm, neural plate and presumptive 
neural crest. Furthermore, signaling molecules involve in the induction of these 
neighboring territories also are responsible for the induction of the preplacodal domain. 
Importantly, the requirement for these signaling pathways is different for the individual 
induction of the aforementioned territories. For instance, the BMP and Wnt pathways are 
required for the establishment of the neural plate border territory while preplacodal 
regionalization requires the inhibition of Wnt and BMP most likely achieved through the 
antagonistic activity of the BMP inhibitor DAN and the Wnt antagonist Cerberus (Streit 
2007). As in neural crest cell induction, FGF8 is also important for the preplacodal domain, 
as well as the otic placode induction. Early over-expression of FGF8 promotes the 
expression of the preplacodal marker eya2 (Brugmann et al. 2004), while missexpression of 
FGF8 leads to an enlarged otic vesicle only within the field where both otic placode 
markers, Foxi and Dlx3b are co-expressed; in addition, FGF8 is required for the induction 
of these two genes (Hans et al. 2004, Hans et al. 2007).  Interestingly, as placode begin to 
segregate into different subpopulations, a trio of SoxE family factors, Sox8, Sox9 and 
Sox10, among other transcription factors, become concomitantly expressed in the otic 
placode. However, their order of expression in the placode is different than in the neural 
crest, with Sox8 expressed first followed by Sox10 in chick. It has been suggested that the 
role of the SoxE genes in the otic placode is similar to their role during neural crest cell 
specification. However, there is not much information regarding this function in the otic. 
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Since the previously described Sox10E2 enhancer is active in both cranial neural crest cells 
and otic placode, I used this Sox10 regulatory region to begin to estabish regulatory 
connections on Sox10 in the otic region. By mutational analysis of the Sox10 regulatory 
fragment and morpholino knock down of upstream putative activators, I located three 
Sox10 activators cMyb, Sox8  and Pea3. It is also intriguingly that the same binding motifs 
within the Sox10E2 regulatory region respond to the input of different sets of 
transactivators to activate initial Sox10 expression in each neural crest and otic placode 
cells. This suggests that Sox10 cis-regulatory machinery has been highly conserved and that 
the differences in deployment of upstream activators may have been the result of 
duplication and divergence during evolutionary changes. 
 
 
Conclusion and future prospects 
 
 In this chapter, I first presented an overview of a gene regulatory network orchestrating  
formation of neural crest cells, focusing on the cranial level. Formulation of this network 
relies on information largely inferred from studies of molecular mechanisms underlying 
neural crest formation in several vertebrate model organisms. I attempted to include all 
known cis-regulatory information obtained to date, providing evidence for direct regulatory 
interactions and architectural circuitry between the molecular factors involved. I briefly 
introduced signaling pathways and factors involved in the induction and specification of 
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the common preplacodal domain in general and the otic placode in particular. However, 
there is little information available at the level of regulatory interactions, let alone 
regarding direct interactions. Finally, I presented how the direct activation of the early 
neural crest Sox10 enhancer by cMyb, Sox9 and Ets1 fits into the neural crest cell gene 
regulatory network.  The characterization of the Sox10E2 enhancer also helps to expand 
knowledge of direct regulatory interactions in the otic placode by placing Sox8 upstream of 
Sox10 and also implicating two new Sox10 regulators, Pea3 and cMyb, in this region. The 
finding that the same enhancer functions in both neural crest and otic placode, while being 
activated by paralogous transcription factors, poses the intriguing possibility of a close 
evolutionary relationship between these two cell types at the regulatory level.  
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Figure 1. Gene regulatory network model (a view from all nuclei) mapping vertebrate 
hierarchical gene regulatory interactions during cranial neural crest cell (CNCC) 
development. The model is built using BioTapestry software (Longabaugh et al 2009). The 
network is partitioned into sub-networks that regroup regulatory interactions during 
induction and specification at the neural plate border, in pre-migratory and migrating neural 
crest cells and in differentiating neural crest derivatives. Most of the linkages in the 
network model are inferred from available gene perturbation data from Xenopus, chicken, 
mouse, zebrafish and lamprey. Direct regulatory interactions, based on promoter and cis-
regulatory analysis, are indicated with solid connector lines. Dash connectors show 
potential direct regulatory interaction inferred from gene perturbation studies. Broken lines 
are used to represent potential interactions that are indirect. Bubble nodes indicate protein-
protein interaction. Transcriptional orientation was not taken into consideration in this case 
since it varies among different vertebrate models.  
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Source Interaction Target System  
 
Evidence 
BMP Promotes * Msx2 Mouse Brugger, 2004 
BMP Promotes Dlx5 Xenopus Luo, 2001 
BMP, FGF, 
Wnt, Notch, 
Gbx2, Dlx5, 
AP-2, Myc 
Promotes Msx1 Xenopus, 
lamprey 
Monsoro-Burq,2005; Tribulo, 
2003; Li, 2009; Woda, 2003; 
Nikitina, 2008 
BMP, Wnt, 
FGF, Gbx2, 
AP-2, Zic, Myc 
Promotes Pax3/7 Xenopus, 
lamprey 
Sato, 2003; Hong, 2007; 
Monsoro-Burq, 2005; Li, 
2009; Nikitina, 2008 
BMP, Wnt, 
FGF, Msx 
Promotes Zic1 Xenopus, 
lamprey 
Sato, 2003; Hong, 2007; 
Nikitina, 2008 
FGF Promotes Zic5 Xenopus Monsoro-Burq, 2003 
Wnt Promotes* Gbx2 Xenopus Li, 2009 
Notch Promotes* Hairy2 Xenopus Glavic, 2004 
Msx Promotes AP-2 Lamprey Nikitina, 2008  
FGF, Hairy2, 
Zic1, Msx1, 
Pax3/7, Gbx2, 
AP-2, Sox9, 
Sox10, Sox5 
Promotes Snail1/2 Xenopus, 
chicken 
Mayor, 1997; Villanueva, 
2002; Glavic, 2004; Sato, 
2005; Tribuolo, 2003; 
Maulemans, 2004; Li, 2009; 
Spokony, 2002; Aoki, 2003; 
Honore, 2003; Perez-Alcala, 
2004 
BMP, Wnt,  Promotes* Snail1/2 Mouse, 
xenopus 
Sakai, 2005; Vallin, 2001  
FoxD3 Represses Snail1/2 Zebrafish Lister, 2006 
Notch Promotes Twist Xenopus Coffman, 1993; Cornell, 2005 
Snail1/2, FoxD3 Promotes 
(Ind) 
Twist Xenopus Aoki, 2003; Aybar, 2003; 
Sasai, 2001; Maulemans, 
2004 
cMyc Promotes* Id Xenopus Light, 2005 
BMP, Wnt, Zic, 
AP-2 
Promotes Id Xenopus, 
lamprey 
Kee, 2005; Nikitina, 2008 
Zic, AP-2 Promotes Myc Lamprey Nikitina, 2008 
Hairy2, Zic1, 
Pax3/7, Msx1, 
Sox10, Sox5 
Promotes FoxD3 Xenopus, 
chicken 
Wettstein, 1997; Sato, 2005; 
Tribulo, 2003; Honore, 2003; 
Perez-Alcala, 2004 
Snail1/2 Promotes 
(Ind) 
FoxD3 Xenopus Aoki, 2003; Aybar, 2003 
TABLE 1. Evidence for gene regulatory interactions in cranial neural crest cells 
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FoxD3 Represses FoxD3 Xenopus Pohl, 2001 
cMyb Promotes Ets1 Chicken Betancur, unpublished data 
Wnt Promotes* Sox9 Mouse Bagueri-Fam, 2006 
Ap-2, Gbx2, 
Zic1, Sox10 
Promotes Sox9 Xenopus, 
mouse 
Lee, 2004; Luo, 2003; Saint-
Germain, 2004; Bagheri-Fam, 
2006; Li, 2009; Honore, 2003 
Id Represses Sox9 Xenopus Light, 2005 
cMyb, Ets1, 
Sox9, Wnt, 
Pax3/7, AP-2 
Promotes*  Sox10 Chicken, 
mouse, 
zebrafish 
Betancur, 2010; Werner, 
2007; Dutton, 2008 
Sox5, Notch, 
NFKappaB 
Promotes Sox10 Chicken Perez-Alcala, 2004; Dutton, 
2008  
Snail1/2 Promotes 
(Ind) 
Sox10 Xenopus Aoki, 2003; Aybar, 2003 
Id Represses Sox10 Xenopus Light, 2005 
Snail1/2 Represses* Cad6B, 
Ecad 
Chicken, 
mouse & 
human cell 
lines 
Taneyhill, 2007; Cano, 2000 
Sox10 Represses 
(Ind) 
Ncad Chicken, 
mouse 
Cheung, 2005 
FoxD3 Represses Ncad Chicken, 
mouse 
Cheung, 2005 
RhoB Modulates Ncad  Groysman, 2008 
FoxD3 Promotes 
(Ind) 
Cad7 Chicken, 
mouse 
Cheung, 2005 
FoxD3 Promotes 
(Ind) 
B1 Integrin Chicken, 
mouse 
Cheung, 2005  
Sox10 Promotes B1 integrin Chicken, 
mouse 
Cheung, 2005 
Sox5 Promotes RhoB Chicken Perez-Alcala, 2004 
Notch Promotes* Hes1/5 HeLa cell 
line 
Jarriault, 1995 
Hes1/5 Promotes GFAP, 
Col2a1 
Mouse Ijuin, 2008 
Sox10, Pax3 Promotes* Mitf Cell lines Verastegui, 2000; Bondurand, 
2001 
Sox5 Modulates* Mitf Mouse Stolt, 2008 
FoxD3 Represses 
(Ind) 
Mitf Quail Thomas and Erickson, 2009 
Sox10, Mitf Promotes* Dct/TRP2 Cell lines Ludwig, 2004 
Sox5 Modulates* Dct/TRP2 Mouse Stolt, 2008 
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Sox10 Promotes * P0, Cx32, 
MBP, 
PMP22 
Mouse, 
cell lines 
Peirano, 2000; Bondurad, 
2001 
Sox10 Promotes Phox2B, 
MASH1, 
Ngn1 
Rat cell 
culture, 
zebrafish 
Kim, 2003; Carney, 2006 
Sox9, Sox5 Promotes* Col2a1 Cell lines, 
mouse 
Lefebvre, 1997; Hattori, 2008 
Sox9 Promotes*               Col11a2, 
CD RAP 
Cell lines, 
mouse 
Bridgewater, 1998; Xi, 1999 
Islet1 Represses Ngn1, 
Lhx1/2, 
Olig1/2 
Mouse Sun, 2008 
         * Direct regulatory interaction (data available)                                                  
            (Ind) Possible indirect interaction 
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Abstract  
 
 The neural crest is a multipotent, stem cell-like population that migrates extensively  
in the embryo and forms a wide array of derivatives ranging from neurons to melanocytes 
and cartilage. Analyses of the gene regulatory network (GRN) driving neural crest 
development revealed Sox10 as one of the earliest neural crest specifying genes, cell-
autonomously driving delamination and directly regulating numerous downstream effectors 
and differentiation gene batteries. In search of direct inputs to the neural crest specifier 
module, I dissected the chick Sox10 genomic region and isolated two downstream 
regulatory regions with distinct spatiotemporal activity. A novel element, Sox10E2 
represents the earliest-acting neural crest cis-regulatory element, critical for initiating Sox10 
expression in newly formed cranial, but not vagal and trunk neural crest. A second element, 
Sox10E1, acts in later migrating vagal and trunk crest cells. Deep characterization of 
Sox10E2 reveals Sox9, Ets1 and cMyb as direct inputs mediating enhancer activity. 
Chromatin immunoprecipitation, DNA-pulldown and gel shift assays demonstrate their 
direct binding to the Sox10E2 enhancer in vivo, whereas mutation of their corresponding 
binding sites, or inactivation of the three upstream regulators, abolishes both reporter and 
endogenous Sox10 expression. Using cis-regulatory analysis as a tool, this study makes 
critical connections within the neural crest GRN, thus establishing the first direct link of 
upstream effectors to a key neural crest specifier. 
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Introduction 
 
 Because of its stem cell properties and numerous derivatives, the vertebrate neural 
crest (NC) represents an excellent system for examining questions of cell specification and 
differentiation during development. Along the neural axis, neural crest cells are subdivided 
into several subpopulations, cranial, vagal, trunk and sacral, distinct in their migratory 
pathways and derivatives. Although the molecular underpinnings of these regional 
differences are unknown, an intriguing possibility is that these may be due to differential 
regulation of neural crest marker genes. Consistent with this, some transcription factors, 
like Id2 and Ets1, are selectively expressed at cranial but not vagal or trunk levels 
(Martinsen and Bronner-Fraser 1998, Tahtakran and Selleck 2003).  
It has been proposed that a gene regulatory network (GRN) defines the regulatory 
state of neural crest cells (Meulemans and Bronner-Fraser 2004), such that modules of 
transcription factors function sequentially to first specify the neural plate border and then 
the nascent neural crest. The intricate regulatory interactions within the NC-GRN start with 
a group of transcription factors comprising an evolutionarily “inflexible” neural plate 
border regulatory unit, whose essential upstream function is to establish identity of the 
progenitor territory (Nikitina N. et al. 2008). Although neural plate border genes are 
thought to regulate genes of the neural crest specification circuit, virtually nothing is known 
about direct regulatory connections between these border and specifier modules. Activation 
of transcription factors in a temporally and spatially controlled fashion assures not only that 
NC cells acquire migratory properties, but also that they differentiate into numerous 
derivatives appropriate for their axial level of origin. Identification of region-specific 
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regulatory elements promises to provide an important tool for understanding how neural 
crest cells are regionally specified and how this relates to the global NC-GRN. 
The present state of knowledge of the NC-GRN has been largely derived from 
transperturbation experiments using morpholino-mediated knock-down in frog, zebrafish 
and chick, generally focused on the cranial neural crest (CNC). Due to the nature of the 
analysis, understanding hierarchical relationships within the NC-GRN has been indirect. As 
a consequence, information directly connecting hypothetical upstream neural plate border 
regulators to neural crest specifiers is sorely lacking. The evolutionary addition of the crest 
specifier link to a neural plate border module, already present in non-vertebrate chordates, 
was a critical step for invention of migratory and multipotent NC cells in the vertebrate 
lineage (Sauka-Spengler and Bronner-Fraser 2006). To fill this void and connect currently 
distant portions of the NC-GRN, cis-regulatory analysis of neural crest specifier genes is 
required. However, this has been classically problematic due to the difficulty of performing 
high throughput regulatory analysis and the paucity of genomic information in those 
vertebrates most amenable to experimental manipulation.  
Previous studies have identified Sox10 as a key regulator of numerous effector 
genes in the NC-GRN. It is critical not only for neural crest delamination/migration but 
also for specification of multiple neural crest lineages (autonomic neurons, glia, 
melanocytes) by directly regulating genes involved in differentiation (Kelsh 2006, Sauka-
Spengler and Bronner-Fraser 2008a). Thus, Sox10 is a linch pin for understanding the 
process of neural crest specification. Although Sox10 enhancer elements controlling 
expression in neural crest derivatives and late migrating cells have been noted in other 
species (Antonellis et al. 2006, Antonellis et al. 2008, Dutton J. R. et al. 2008, Werner et al. 
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2007), no regulatory element(s) controlling initial activation of any neural crest specifier, 
let alone Sox10, has been uncovered to date. 
Here, I provide the necessary cis-regulatory analysis that links activation of Sox10 
in newly formed cranial neural crest cells within the NC-GRN. By dissecting the cis-
regulatory regions of this essential neural crest specifier, I have isolated two enhancers with 
distinct regulatory activities. Mutational analysis, reveal previously unknown cis-regulatory 
inputs active in nascent cranial neural crest cells. Three transcription factors, Sox9, Ets1 
and cMyb, acting via the newly identified enhancer Sox10E2, are required for direct initial 
activation of endogenous Sox10 expression and the specification of delaminating/migrating 
cranial neural crest. This study adds additional, previously uncharacterized players to the 
early phase of the NC-GRN. By establishing direct regulatory connections to Sox10 
activation within the cranial neural crest, the data add important information for decoding 
and understanding the NC-GRN as a whole. 
 
Results and Discussion 
 
Identification of Sox10 genomic fragments with regulatory activity in newly formed 
neural crest  
To guide experimental tests of regulatory activity, comparative genomic analysis 
was employed to identify conserved elements. Genomic sequences surrounding the Sox10 
coding region from chicken, zebrafish, Xenopus, opossum, mouse, rat and human were 
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compared in silico (Fig1. A), employing the ECR Browser program 
(http://ecrbrowser.dcode.org/). Using Sox10 BAC clone, genomic fragments of ~3-5kb, 
containing one or more conserved regions (>70% homology), were cloned into EGFP 
reporter vector upstream of thymidine kinase (tk) basal promoter (Uchikawa et al. 2003) 
and functionally tested in vivo for ability to recapitulate Sox10 expression during early 
neural crest formation. Using an ex ovo and in ovo electroporation techniques (Sauka-
Spengler and Barembaum 2008), the entire epiblast of stage 4 chick embryos, according to 
Hamburger and Hamilton (HH), or dorsal neural tube of stage HH8-12 embryos were 
transfected with reporter construct (green), together with a pCI-H2B-RFP (red) ubiquitous 
tracer to assess transfection extent and efficiency. Embryos were collected after 8-48 hrs 
(HH8+-18), fixed and analyzed for EGFP expression.  
The results reveal a 3.5kb fragment, ~1kb downstream of the Sox10 coding region, 
that activates EGFP reporter expression (Figs. 1B-F) in a manner that recapitulates 
endogenous Sox10 transcription (Figs. 1G-J), as the neural crest delaminates and migrates 
from the neural tube. EGFP transcripts were detected in cranial neural crest cells as early as 
HH8+ (Fig. 1B), in embryos with 6 somites, when Sox10 is first distinguishable by in situ 
hybridization (Fig. 1G). Both the EGFP reporter and endogenous Sox10 were maintained 
on actively migrating cranial neural crest (Figs. 1D, F, I) as expression initiates 
progressively caudally (Figs. 1I, J; (Cheng et al. 2000)). However, while endogenous Sox10 
is down-regulated as crest cells enter the branchial arches (Fig. 1J), expression of the EGFP 
reporter was maintained in branchial arches (similar to SFig. 2b). Both Sox10 and EGFP 
were also expressed in otic placode cells by stage HH10 (Figs. 1C, H) and later, more 
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caudally, in actively migrating, but not early delaminating vagal and trunk neural crest 
(Figs. 1D, E, I, J).  
Thus, this 3.5kb Sox10 genomic fragment (denoted Sox10E) contains regulatory 
modules that mediate initial Sox10 activation during early neural crest delamination at the 
cranial but not more caudal levels. Of six other fragments upstream of the coding region, 
five lacked functional activity at the time points of interest. Another 5kb fragment, denoted 
Sox10L8 (Fig. 1A), exhibited weak EGFP activity in neural crest and otic cells by HH13 
(6/6), but not in emigrating neural crest and therefore was not pursued further. 
 
Two highly conserved regions within Sox10E genomic fragment activate distinct 
spatiotemporal reporter expression 
I used the ECR browser program to search for highly conserved sequences, 
potentially representing minimal essential core regulatory elements. By screening for 70% 
conservation across 100bp windows within multiple aligned genomic regions between 
Sox10 and POLR2F, the first downstream neighboring gene, the program revealed two 
clusters of ~160bp and ~267bp within the 3.5kb Sox10E fragment (Fig. 2A). As no 
recognizable sequence homology was observed with either zebrafish or Xenopus 
sequences, these species were excluded. While there are no studies addressing Sox10 
regulation in Xenopus, in zebrafish a 4.9 kb region upstream of Sox10 can recapitulate 
endogenous Sox10 expression in sox10:GFP transgenics (Carney et al. 2006). Interestingly, 
despite the lack of obvious sequence conservation between their corresponding genomic 
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regions murine Sox10 regulatory elements drive reporter expression in transgenic zebrafish 
in similar spatial, but not completely overlapping temporal patterns, to those observed in 
transgenic reporter mice (Antonellis et al. 2008). Rather than using conventional sequence 
conservation approach, the search for conserved smaller motifs in a constrained 
arrangement has led to identification of a zebrafish Sox10 enhancer, further confirming that 
regulatory factors controlling Sox10 expression across vertebrate appears conserved 
(Dutton J. R. et al. 2008). Assaying two smaller fragments, each containing one identified 
conserved region, revealed that they activated EGFP expression in spatially distinct 
populations and in temporally distinct manners. A 600bp Sox10E1 fragment lacked activity 
in emigrating or migrating cranial crest (SFigs. 2a, d). It was first active in migrating vagal 
crest at HH15 (Fig. 2C) and in trunk crest, otic vesicle and condensed trigeminal ganglia 
(Fig2. D, Table1 on Fig. 2E), but did not drive EGFP expression in delaminating vagal or 
trunk neural crest.  
Systematic deletions within the Sox10E region revealed a second active region--a 
264bp minimal enhancer fragment, Sox10E2, comprised of an essential highly conserved 
160bp core and supporting elements within 59bp upstream thereof (SFig. 1). In contrast to 
the late activating Sox10E1, Sox10E2 displayed enhancer activity as early as HH8+ in the 
first cranial crest emigrating from the neural tube, mimicking Sox10E activity (Fig. 1B) 
that intensified through HH9 (Fig. 2B). At HH12-15, Sox10E2 reporter expression was 
maintained in periocular crest, rostral hindbrain streams and otic vesicle (OV: SFigs. 2b, e), 
but absent from caudal hindbrain or trunk levels (SFig. 2b, c, e, f). Just as Sox10E displays 
regulatory activity within the branchial arches, Sox10E2 drives EGFP expression in rostral 
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hindbrain crest populating the first two arches (SFigs. 2b, e), and Sox10E1 is active in 
vagally-derived (r6-8) crest of posterior branchial arches (BA3-5; Fig. 2D). In contrast, 
endogenous Sox10 is downregulated upon entering the arches (Fig. 1J). This ectopic 
expression suggests loss of a repressor element from the Sox10E fragments. The results 
show that both cis-regulatory fragments (Sox10E1/E2) can regulate Sox10 expression in 
neural crest and otic regions, but in spatially and temporally distinct patterns. Interestingly, 
each reflects a portion of endogenous Sox10 expression, which initiates in a rostrocaudal 
temporal sequence (Table1 on Fig. 2E). Fragment Sox10E1 is conserved and exhibited 
similar expression to a previously identified mouse D6 enhancer (Fig. 2A) (Werner et al. 
2007). In contrast, no conserved region homologous to Sox10E2 has been reported.  
 
Binding motifs for SoxE, Ets and Myb are necessary for Sox10E2 regulatory activity 
To identify putative transcription factor binding sites within the 264bp Sox10E2 
regulatory fragment, the corresponding sequences from human, mouse, rat, opossum and 
Xenopus genomic regions were aligned to chicken and screened for conserved motifs. 
Concomitantly, sequences were analyzed for known transcription factor consensus sites 
using Transfac 7.0, rVista and Jaspar programs. This revealed three highly conserved 
binding motifs (100% across amniotes), two for SoxE proteins and one for Ets factors. 
Conservation of other putative binding motifs ranged from 50-80% (Fig. 3A). 
Computationally identified binding motifs within Sox10E2 were tested for function via 
mutation/deletion analyses. Mutated versions of Sox10E2-EGFP constructs were generated 
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for individual putative binding motifs, electroporated into chicken embryos, and analyzed 
after 10-12 hrs (HH10-12).  
Mutation of a putative Ets binding motif, within the enhancer core (M9;Fig3A), 
completely abolished Sox10E2 expression (Fig. 3C; 8/8). Similarly, reporter activity in 
cranial neural crest (SFig. 3b) was eliminated upon mutation of either SoxE binding site 
within the essential core region (M8, M11; Fig. 3A), indicating both were required for its 
activity (SFig. 3b; 13/13). Interestingly, there are two putative binding motifs for Myb 
factors in Sox10E2, one within the core and the other in the upstream adjacent supporting 
region (M2, M12; Fig. 3A), each contributing to regulatory activity. When both were 
replaced with random sequences, this double mutation completely abolished reporter 
expression (SFig. 3c; 7/7). Individual mutation of other computationally identified motifs 
only reduced enhancer activity. Perturbations of SoxD (M13; 10/10), Elk/Ets (M4; 7/7) and 
single Myb (M2,M12; 6/6) sites diminished EGFP signal intensity (Fig. 3A, D; SFig. 3d) 
suggesting they enhance regulatory function. In contrast, several mutations had no effect; 
e.g. simultaneous mutation of 4 putative Pax binding sites (M1, M3, M5, M7; Fig. 3A, E; 
7/7), deletion of 45bp within the core region (Fig. 3A faded portion; 11/11), or mutation of 
either NFkB binding site (M6, M10; SFig. 3e; 6/6). Taken together, these results show that 
SoxE, Ets and Myb binding motifs are each necessary for Sox10E2 regulatory function. In 
addition to neural crest expression, these mutations also affected expression of the 
Sox10E2 reporter in the otic placode.  
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I tested whether SoxE, Ets and Myb binding sites, within the 264bp Sox10E2 
fragment, are essential for regulatory activity of a larger construct from the Sox10 locus. To 
this end, I mutated these same sites (M2, M8, M9, M11, M12; Fig. 3A) within a much 
larger genomic fragment (~3.5kb) to test whether other genomic regions surrounding these 
enhancers could compensate for the loss of activity. Whereas the full length, non-mutated 
construct gave robust GFP staining that recapitulated endogenous Sox10 expression, 
reporter activity in delaminating neural crest was completely eliminated in the same 
construct bearing mutations in SoxE, Ets and Myb binding sites within Sox10E2 (Fig. 3F; 
6/6). These results strongly suggest that 264bp Sox10E2 fragment represents an essential 
regulatory module, and that binding sites for SoxE, Ets and Myb proteins are absolutely 
required for early Sox10 expression within the context of the Sox10 locus. 
 
Knockdown of Ets1, cMyb or Sox9 diminishes Sox10E2 regulatory activity 
To test if Ets1, cMyb and Sox9 transcription factors are required for exogenous 
Sox10E2 regulatory activity in delaminating neural crest, I co-electroporated either Ets1, 
cMyb, or Sox9 morpholino with the Sox10E2 reporter construct. The right side of each 
embryo received morpholino plus Sox10E2 reporter, whereas the left side received reporter 
plasmid alone. When the reporter construct was co-electroporated with control morpholino, 
the reporter signal on the right side was unaffected and comparable to the contralateral side 
(Figs. 4A-C; 10/10). Conversely, in the presence of cMyb (Figs. 4D-F; 11/15), Ets1 (Figs. 
4G-I; 13/15), or Sox9 morpholino (SFig. 4;15/15) expression was greatly decreased or 
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abolished. These results show that Ets1, cMyb and Sox9 are independently required for the 
normal Sox10E2 regulatory activity, therefore making them good candidate factors 
responsible for the initial regulation of Sox10 through the identified Ets, Myb and SoxE 
functional binding motifs within Sox10E2.  
Knockdown of Ets1, cMyb or Sox9 diminishes endogenous Sox10 expression  
Although cMyb transcripts have been detected in early embryogenesis (Karafiat et 
al. 2005), their distribution was unknown and has not been described within the context of 
the neural crest gene regulatory network.  Results obtained by in situ hybridization show 
that cMyb is expressed at stage HH6 in the neural plate border (Fig. 4J), and that transcripts 
accumulate in the neural folds by HH8, with strongest expression at the dorsal margins 
containing neural crest precursors (Figs. 4K, K’). At HH10, transcripts are seen in neural 
crest cells delaminating and emigrating from the cranial neural tube (Figs. 4L, L’). Thus, 
cMyb, like Sox9 (Fig. 4M) and Ets1 (Fig. 4N), is expressed in presumptive cranial neural 
crest prior to Sox10. The presence of cMyb at the neural plate border and premigratory 
neural crest illuminates a new role, at the onset of Sox10 expression, in neural crest cell 
specification. Its initial expression coincides with that of early neural crest specifiers such 
as AP-2, c-Myc or Snail2. Furthermore, overexpression of cMyb upregulates Msx1 and 
Snail2, and may participate in BMP4 input into the epithelial-mesenchymal transition of 
trunk neural crest (Karafiat et al. 2005). 
I performed in vivo validation that endogenous Ets1, Sox9 or cMyb proteins are 
required as upstream regulators of Sox10 in delaminating crest in vivo by examining the 
effects of cMyb, Ets1 or Sox9 morpholinos on endogenous Sox10 expression at HH8+-9. 
The results reveal a dose-dependent effect on Sox10 expression on the electroporated 
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versus contralateral side. I observed a mild diminution when individual morpholinos were 
electroporated at 1mM (Sox9 3/3; cMyb 9/10; Ets1 7/10), but a marked decrease at 3mM 
(Sox9 n=5, cMyb and Ets1 n=6, p<0.02; Fig. 5A-C, E-G). The effect of cMyb knockdown 
was less strong than either Ets1 or Sox9 inactivation (phenotypes ranging from 50-75% 
loss in Sox10 transcript). In contrast, electroporation of a control morpholino had no effect 
(10/10;Figs. 5L, M) and co-electroporation of morpholinos with the corresponding mRNAs 
mutated within the morpholino target region successfully rescued the loss-of-function 
phenotype (Sox9,n=6, p<0.03; cMyb n=5, p≤0.04; Ets1,n=5, p<0.03; Figs. 5I-K). No 
statistically significant differences were noted in phosphohistone H3 or TUNEL staining 
between electroporated and control sides of embryos receiving either individual or all three 
morpholinos (~3mM). Thus, changes in cell proliferation or cell death cannot account for 
loss of Sox10 transcript (SFig. 5). The cumulative results suggest that Sox9, cMyb and Ets1 
are each required for expression of endogenous Sox10. Importantly, the combined 
electroporation of all three morpholinos virtually eliminated transcript expression on the 
electroporated side (n=6, p≤0.01; Fig. 5D, H). Our data confirm that Sox9, cMyb and Ets1 
together are necessary for initial activation of Sox10.  
 
Sox9, Ets1 and cMyb ectopically activate and are required for Sox10E2 reporter 
expression 
All three SoxE genes, Sox8, Sox9 and Sox10, are expressed by neural crest 
progenitors (Haldin and Labonne 2009). Because these genes can act redundantly (Finzsch 
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et al. 2008, Stolt et al. 2004, Taylor and Labonne 2005), theoretically any could activate the 
Sox10E2 reporter construct within the endogenous context. In all vertebrates examined, 
however, Sox9 expression precedes Sox10 (Antonellis et al. 2006, Dutton J. R. et al. 2008, 
Hong and Saint-Jeannet 2005, Werner et al. 2007); e.g. chick Sox9 is expressed in dorsal 
neural folds as early as HH8, before either Sox10 or Sox8 (Cheung and Briscoe 2003). This 
narrow (4-6 hr) time delay and the Sox9 morpholino knock down results presented in this 
study, suggest that Sox9 directly regulates Sox10 onset and that this SoxE protein is 
responsible for initiating Sox10 expression. To test if Sox9 can regulate the identified 
Sox10E2 regulatory element, Sox9 protein was ectopically expressed using ubiquitous 
H2B-RFP expression vector. Whereas no ectopic reporter expression was seen when 
Sox10E2 reporter was co-electroporated with control plasmid (Figs. 6A, F; 9/9), co-
electroporation with Sox9 plasmid caused ectopic reporter activity in extraembryonic 
region (Figs. 6B, G; 6/6). Similar results were obtained when cMyb was ectopically 
expressed (Figs. 6D, I; 3/3). Because Sox9 is expressed only transiently in migrating neural 
crest cells, it is likely that Sox10 and/or Sox8 later act to maintain Sox10 expression.  
Interestingly, co-electroporation of Ets1 plasmid with Sox10E2 reporter resulted 
in ectopic reporter activation not only in extraembryonic regions but also in the trunk 
neural tube, which normally does not express Ets1 (Tahtakran and Selleck 2003) 
(arrowheads;Figs. 6C, H; 12/12). In the embryo, Ets1 plays a role in cranial neural crest 
delamination and appears to mitigate the requirement for S phase synchronization to 
promote crest emigration in a cluster-like fashion. Moreover, ectopic expression of Ets1 
in the trunk results in excess, cluster-like emigration of Sox10-expressing cells 
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(Theveneau et al. 2007). Since expression of both Ets1 and the Sox10E2-driven reporter 
is cranial-specific, it is intriguing to speculate that this newly identified element may act 
as one of the switches distinguishing head and trunk crest populations. Since Sox9 and 
cMyb, but not Ets1, are normally expressed in the trunk neural tube (Cheung and Briscoe 
2003, Karafiat et al. 2005, Tahtakran and Selleck 2003), ectopic Ets1 in this location may 
cooperate with these other factors to induce reporter expression. In support of this, 
combined overexpression of Sox9, Ets1 and cMyb has a broader effect and induces strong 
ectopic Sox10E2 expression not only extraembryonically, but also along the neural tube, 
and in the ectoderm (SFig6a,d;5/5). 
Sox9, Ets1 or cMyb are each sufficient to trigger ectopic Sox10E2 enhancer 
activity. However, mutation of individual binding motifs or knock down of individual 
factors in the endogenous context shows that all three factors are necessary for normal 
Sox10E2 regulatory activity. Since ectopic reporter activity driven by overexpression of 
individual transcription factors occurs mainly in the extraembryonic region, we speculate 
that these naïve cells may already contain regulatory factors characteristic of multipotent 
tissue and are, thus, competent to switch on a neural crest-like transcriptional program in 
response to the proper single inputs.  
To test if regulatory activity is mediated via the corresponding binding motifs of 
Sox9, Ets1 and Myb within Sox10E2 enhancer, I assayed their ability to ectopically 
activate mutated reporter constructs. Either Sox9-H2B RFP (6/6) or cEts1-H2B RFP (6/6) 
were co-electroporated with Sox10E2 construct with corresponding binding motif 
mutations. In all cases, electroporated embryos lacked ectopic reporter expression (Figs. 
6E, J). However, ectopic reporter expression was also affected when overexpressing either 
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Ets1, cMyb or Sox9 with other Sox10E2 versions containing mutations within non-cognate 
biding sites. For example, when Sox9 and cMyb were overexpressed and combined with a 
Sox10E2 reporter carrying a mutation within the Ets motif (M9), ectopic reporter 
expression in the extraembryonic region was not observed (SFigs. 6b, e; 6/6). If Sox9 and 
Ets1 were over expressed together with a Sox10E2 carrying a single mutated Myb site 
(M12), ectopic reporter expression was weak (SFigs. 6c, f; 3/3). This shows that for the 
Sox10E2 enhancer to have ectopic regulatory activity all binding sites need to be 
functional, and suggests a cluster-like conformation of the motifs and synergistic action of 
the corresponding upstream regulators. 
 
Sox9, Ets1 and cMyb directly bind to the Sox10E2 element 
To test if Sox9, Ets1 and cMyb can bind directly to the corresponding motifs within 
the Sox10E2 element, EMSA assays were performed, using biotinylated double stranded 
oligonucleotides containing the corresponding Sox10E2 sub-fragments (underlined,Fig3A). 
A clear electrophoretic shift was observed in samples incubated with nuclear extracts from 
chicken embryonic fibroblasts overexpressing Sox9, Ets1 or cMyb, but not from the cells 
transfected with control plasmid (white arrowheads;Fig6K). This binding was out-
competed by adding 200-fold excess of the corresponding non-labeled (cold) fragment to 
the binding reaction showing specificity. Next, to confirm the identity of the transcription 
factors directly binding to Sox10E2 subfragments, a streptavidin-biotin DNA pulldown 
approach was used followed by Western blot with specific antibodies. Using biotinylated 
target and scrambled control fragments as bait, it was show that specific subfragments pull 
down corresponding binding proteins (Sox9, Ets1 and cMyb) from the embryonic nuclear 
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extracts. Conversely non-coated streptavidin-conjugated magnetic beads or beads coated 
with scrambled control fragments display no specific protein binding (Fig6L).  
Finally, the direct binding of these transcription factors to the Sox10E2 enhancer in 
vivo using quantitative ChIP (qChIP) was tested. Crosslinked chromatin isolated from 
cranial regions of HH8-12 somite embryos was immunoprecipitated using Sox9, Ets1 and 
cMyb antibodies and ChIP-enriched DNA was used in site-specific QPCR, with primers 
designed to amplify fragments within the Sox10E2 region.  Results show significant (4-8X) 
enrichment over non-specific antibody indicating that Sox10 locus and, in particular, 
Sox10E2 regulatory element, was occupied by endogenous Sox9, Ets1 and cMyb proteins 
in the cranial region of HH8-10 chicken embryos (Fig6M).  
  
 
Conclusion 
 
In summary, I have isolated and dissected a novel regulatory module, representing 
the first known element responsible for driving gene expression in newly emigrating 
cranial neural crest cells. Of the neural crest specifiers, Sox10 is a key regulator for 
specification of numerous genes important for neural crest migration and differentiation 
(Kelsh 2006, Sauka-Spengler and Bronner-Fraser 2008a). Although Sox10 enhancer 
elements controlling expression in neural crest derivatives and late migrating cells have 
been noted in other species (Carney et al. 2006, Deal et al. 2006, Werner et al. 2007), this is 
the first report of a regulatory element(s) controlling onset of any neural crest specifier. I 
find that a cluster of transcription factors, Ets1, Sox9 or cMyb, directly converge onto this 
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cis-regulatory element to regulate the reporter and onset of endogenous Sox10 expression 
in cranial neural crest cells. This introduces and establishes the role of two new neural crest 
specifier genes, cMyb and Ets1, in the NC-GRN and confirms Sox9 as an essential input 
into Sox10 specific activation at the cranial level. Such in depth analysis combining 
perturbations of regulatory sequences and their candidate upstream regulators, substantiated 
with EMSA, DNA pulldown and chromatin immunoprecipitation assays, provides 
powerful tools for identifying direct binding interactions and testing regulatory outcomes in 
vivo. By connecting upstream regulators of the NC-GRN directly to Sox10 via the cranial 
crest enhancer Sox10E2, new elements to the NC-GRN can be added to expand our 
knowledge of its architecture. 
 
 
Materials and Methods 
 
Ex ovo/in ovo electroporations 
Chicken embryos were electroporated at stages HH4-8 to target the cranial neural 
crest cell population and at stages HH10-12 to target vagal and/or trunk neural crest cells 
following previously described electroporation procedures (Sauka-Spengler and 
Barembaum 2008). In ex-ovo experiments, the DNA plasmid constructs (enhancer driven 
reporter with ubiquitously-expressing tracer) were introduced in the entire epiblast of the 
early chicken embryo, while in in-ovo electroporations only one half of the neural tube 
received the DNA. Injected DNA plasmid concentrations were as follows: 2µg/µl of ptk-
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EGFP or ptk-Cherry reporter construct, containing each of Sox10 putative cis-regulatory 
regions or the Sox10E2 mutated versions, combined with 1µg/µl of either tracer (pCI H2B-
RFP) or expression constructs (Sox9-pCI H2B-RFP or Ets1-pCI H2B-RFP).  
Morpholino-mediated knock-down experiments were performed by injecting the 
translation-blocking, FITC-labelled morpholino antisense oligonucleotides in one half of 
the epiblast (right to the primitive streak) or, in some cases, by double electroporations to 
differentially transfect each half of the embryo ex-ovo. Double electroporations were 
performed by introducing each morpholino combined with the Sox10E2-Cherry plasmid on 
the right side and the Sox10E2-Cherry reporter only on the left side of the embryo. 
Morpholinos used in this study were obtained from Gene Tools (Philomath, OR) and their 
sequences are as follows:  
Ets1_5’-GCTTCAGGTCCACCGCCGCCTTCAT-3’; 
cMyb_5’-ATGGCCGCGAGCTCCGCGTGCAGAT-3’; 
Sox9_5’-GGGTCTAGGAGATTCATGCGAGAAA-3’; 
Control_5’-ATGGCCTCGGAGCTGGAGAGCCTCA-3’. 
  
Microscopy and inmunohistochemistry 
The electroporated embryos were collected at different stages, fixed in 4% 
paraformaldehyde O/N and then washed three times in PBS at room temperature. A Zeiss 
Axioskop2 Plus fluorescence microscope equipped with the AxioVision software was 
employed to image the embryos. Images were processed using Adobe Photoshop CS2. 
After imaging, embryos were cryo-protected in two steps: 15% sucrose/PBS and 7.5% 
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gelatin/15% sucrose/PBS, equilibrated and mounted in 20% gelatin/PBS and frozen in 
liquid nitrogen. 12µm cryosections were collected on Super Frost Plus slides (Fischer 
Scientific, Pittsburgh, PA) and de-gelatinized for 2x10 minutes at 42°C in PBS. To 
intensify EGFP signal, the sections were washed 4x in PBS for 5 minutes, blocked for 1 
hour in 10% donkey serum / PBTW (PBS/0.1% Tween-20) and stained with 1:1000 anti-
GFP primary antibody (Abcam Inc., Cambridge, MA) followed by 1:2000 donkey anti-
goat Alexa-Fluor 488-conjugated secondary antibody (Molecular Probes). Sections were 
subsequently washed, cover-slipped and imaged using the same imaging procedure 
described for the whole-mounts. 
 
Isolation of regulatory regions and cloning  
Sox10 genomic regions were amplified with Expand High Fidelity Plus PCR 
System (Roche Applied Science, Indianapolis, IN), using BAC DNA clones as the template 
(Chicken BAC library Chori 26, BACPAC Resources, Oakland, CA). Each fragment, 
ranging from ~3kb-5kb in size, was cloned into the SmaI-linearized ptk-EGFP vector. The 
ptk-EGFP reporter vector has the Herpes simplex virus thymidine kinase basic promoter 
upstream of enhanced GFP and was a kind gift of Dr. Hisato Kondoh. The clones with the 
appropriate orientation were identified by colony PCR and sequenced. The plasmid DNA 
of the correct clones was prepared and purified using the Endo-free maxi kit (Qiagen) and 
eluted in EDTA-free buffer.  
ptk-Cherry and pCI H2B-RFP plasmids were generated for use in this study. ptk-
Cherry reporter vector was made by swapping EGFP with Cherry fluorescent protein in the 
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ptk-EGFP reporter vector (Uchikawa et al. 2003). pCI H2B-RFP, a tracer construct that 
yields ubiquitous expression under the control of chicken beta actin promoter is a 
bicistronic vector allowing for exogenous expression of proteins of interest and of a fusion 
protein of human histone 2B and monomeric RFP protein, translated from the IRES. The 
pCI H2B-RFP construct was made by replacing the 3xNLS-EGFP sequence within the 
pCI-GFP vector (Megason and McMahon 2002) with the H2B-mRFP1 sequence. 
 
Dissection of Sox10 downstream putative regulatory region and mutation of candidate 
binding sites 
The 3.5kb genomic region downstream Sox10 coding (Sox10E) was divided into 
smaller regions, dissected and mutated fragments amplified using Expand High Fidelity 
Plus PCR System (Roche Applied Science, Indianapolis, IN). For the initial dissection of 
the Sox10E fragment, the following primers were used: 
Sox10E1_ 5’, 5’-ATTAGGTACCTCTGATACAGATGCAAGGCTG-3’ and Sox10E1_ 
3’, 5’-TAATCTCGAGAATTTGCAGCACTGTGGCCTT-3’; 
 Sox10E2_5’, 5’-AATTGGTACCGGCAAGAGTGGCAATTTAACC-3’ and 
Sox10E2_3’, 5’-ATTACTCGAGATTGCTTCCCCCTAGACAGTT-3’;  
Sox10E3_5’, 5’-TTTTGGTACCTAACCAGGGAGGAGTTGTGG-3’ and Sox10E3_3’, 
5’-AATTCTCGAGAAGGCCCACAGCAGAGTG-3’.  
To perturb candidate binding sites within the Sox10E2 fragment, we used single or 
fusion PCR (Heckman and Pease 2007, Szewczyk et al. 2006). Only the primers bearing 
the mutations are listed here. Mutated regions are underlined, the mutated nucleotides are 
shown in bold  and fusion primer sequences are italicized: 
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First 2 Pax sites clusters  
(M1,M3)_5’,5’-
AATTGGTACCGGCAAAGCCCATGATTTAACCTACAACTGCTGAGCTTGTAGG
A AGCCCATGGGCGACTGTGCTTCCGGCT-3’;  
Myb(M2)_5’,5’-
ATTAGGTACCTGGCAAGAGTGGCAAGGGATGGACTGGTAGATGGAAGTGTA
GGACTGTGACTGGCGA-3’;  
Second 2 Pax sites clusters  
(M5,M7)_3’,5’-
TCCCTGCTCCTGCTGCTTATCATGGGCTGGGATCCCCTTTCATGGGCTCTGCCC
CAGCCGGAAGCACAGT-3’; 
 Ets/Elk(M4)_5’,5’-
ATTAGGTACCTGGCAAGAGTGGCAATTTAACCTACAACTGCTGAGCTTGTAGG
ACTGTGACTGGCGACTGTATGGTTAATTGGGGCAGTGCCACTGAAA-3’;  
NFKB1(M6)_3’,5’-
TGCTGCTTATCAGTGATGAGCCCATGGTCTCAGTGGCACTGCCCCAG3’; 
Lef/Tcf/SoxE(M8)_3’,5’-
TCTCATCAAATCACCTCCATCTACCCTGCTCCTGCTGCTTATCAGT-3’;  
Ets(M9)_3’,5’-
AATTCTCGAGATTGCTTCCCCCTAGACAGTTGGGCCTTTGTGCCCTGAGCAGGT
TGCTGTGGAAACCCCCAATGGGCTCTCTGGCCAGAGCTGGCT-3’;  
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NFKB1/Lef/Tcf/Ets1_3’,5’-
AATTCTCGAGTTGCTTCCCCCTAGACAGTTGGGCCTTTGTGCCCTGAGCAGGTT
GCTGTGGAGCCCATGGTCTTCCTCTCTGGCCAGAGC-3’;  
SoxE/Lef/Tcf(M10)_3’,5’-
ATTACTCGAGATTGCTTCCCCCTAGACAGTTGGGCGTATGCGCCCTGAGCAGG
TTGCTGTGGAAA-3’;  
Myb(M11)_3’,5’- 
ATTACTCGAGATTGCTTCCCCCTACTCCATAAGGCCTTTGTGCCCTGAGCA-3’;  
SoxD (M12)_3’, 5’-ATTACTCGAGGCCAATTCCCCCTAGACAGTTGGGC-3’; 
 Δ1_3’,5’-AATTTCCTCTCTGGCCAGAAAATCACCTATTGTTTCCCT-3’;  
R1_3’,5’-
AATTTCCTCTCTGGCCAGCCTCGGGGTACATCCGCTCGGAGGAGGCCTCCCA
GCCCATGGTCTAAATCACCTATTGTTTCCCT-3’.  
After PCR amplification, each fragment was purified using PCR product 
purification kit (Qiagen) and cloned into KpnI/XhoI digested ptk-EGFP or ptk-Cherry 
reporter vectors. 
 
Over expression constructs  
Open reading frames of chick Sox9, cMyb and Ets1 genes were amplified from full 
length cDNA clones or chicken cDNA (Sox9 cDNA clone was a kind gift from Yi-Chuan 
Cheng, Ets1 clone was isolated from the stage 8-12 somites chicken macroarrayed cDNA 
library constructed by Laura Gammill (Gammill and Bronner-Fraser 2002)) and cloned into 
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XhoI/EcoRV or XhoI/ClaI digested pCI H2B-RFP expression vector. The Sox9 and Ets1 
rescue constructs were generated from expression constructs by PCR, using primers 
carrying mutations within the morpholino target sites that do not alter the amino acid 
sequence of the recombinant proteins. The following primers were used:  
Sox9_5’, 5’-AATTCTCGAGGCCACCTGCTCAAGGGCTACGACTGG-3’ and Sox9_3’, 
5’-ATTAGATATCTTTAAGGCCGGGTGAGCTGC-3’;  
Ets1_5’, 5’-AATACTCGAGGGCCTCAACCATGAAGGCGGCGGTGGA-3’ and 
Ets1_3’, 5’-ATTAGATATCTCACTCATCAGCATCTGGCTTG-3’;  
cMyb_5’,5'-ATTACTCGAGgccaccATGGCCCGGAGAC;  
cMyb_3',5’-ATTAATCGATTCACATCACCAGAGTCC;  
Sox9mut_5',5’-ATTACTCGAGgccaccATGAActTgtTgGAtCCCTTCATGAAAATGAC; 
Ets1mut_5’,5'-
ATTACTCGAGTCAACCATGAAaGCtGCcGTcGAttTaAAaCCCACCCTGACCATCA. 
 
Comparative genomic analyses 
To identify highly conserved genomic regions, the ECR Browser software 
(http://ecrbrowser.dcode.org/) was employed. Chicken, zebrafish, Xenopus, opossum, 
mouse, chimpanzee, dog, rat and human genomic sequences were downloaded using 
UCSC genome browser (http://genome.ucsc.edu/) Following instructions available on the 
ECR website, these sequences were computationally compared from between all the 
species, with conservation parameters set to 70-80%.  The “zoom in” feature, built into the 
program, was used to closely analyze the sequence conservation by increasing the threshold 
up to 90% and using different window sizes ranging from 20bp to 50bp.  
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To search for putative binding motifs, we used the jaspar_core database from Jaspar 
(http://jaspar.genereg.net/cgi-bin/jaspar_db.pl) and the P-Match program available through 
the Transfac database (http://www.gene-regulation.com/pub/programs.html). Briefly, the 
264bp-long sequence of Sox10E2 genomic fragment was uploaded into these programs 
using desired parameters and the programs returned potential binding motifs based on the 
position weight matrix (PWM) score. Simultaneously, using rVista 2.0 
(http://rvista.dcode.org/), Sox10E2 sequence was aligned and compared to the 
corresponding mouse sequence to screen the latter sequence for conserved putative binding 
motifs identified in chicken by either Jaspar, Transfac or both search engines. We used the 
position weight matrix (PWM) score, a value given to a site based on the distribution 
frequency of each base at each position (Hollenhorst et al. 2007) to determine the 
probability of binding score. This was then used to guide mutational analysis, since, as with 
any informatics approach, there are several caveats: 1) this only predicts motifs for factors 
with known consensus sites; 2) not all functional sites have high PWM scores since they 
can differ greatly from consensus (Bajard et al. 2006); and 3) not all sites with high PWM 
are functional. 
 
In situ hybridization 
Whole-mount in situ hybridizations were performed using a procedure previously 
described (Wilkinson 1992). Fluorescent in situ procedure using GFP probe was adapted 
from (Acloque et al. 2008). With the exception of the Sox9 and Sox10 probes, which were 
prepared using full length cDNA constructs (a gift from Yi-Chuan Cheng) as a template, all 
other digoxigenin-labeled antisense RNA probes were prepared from chicken EST clones
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obtained from ARK Genomics and MRC Geneservice. Sox10 template was digested with 
HindIII, while all EST clones were linearized using NotI restriction enzyme. All antisense 
RNA probes was synthesized using T3 RNA polymerase, according to standard protocols. 
 
Chromatin immunoprecipitation with Sox9, Ets1 and cMyb antibodies 
For each preparation of nuclei, cranial regions from 20 stage HH8-12 somite 
embryos were dissected in Ringer’s solution and transferred to 1ml isotonic buffer (0.5% 
Triton X-100, 10mM Tris-HCl, pH 7.5, 3mM CaCl2, 0.25 M sucrose, protease inhibitor 
tablet (Complete Protease Inhibitor EDTA-free, Roche), 1 mM DTT, and 0.2 mM PMSF) 
on ice (Buchholz et al. 2006). Tissue was homogenized using Dounce homogenizer  and 
cells cross-linked by adding formaldehyde to a final concentration of 1% and nutated for 
10’ at room temperature. Glycine (final concentration of 125mM) was added to stop the 
cross-linking reaction and the solution was incubated by nutation for 5’ at RT. The cross-
linked cells were washed 3 times and cell pellets were snap frozen in liquid nitrogen and 
kept at -80°C until the ChIP procedure. Preparations were kept up to a month without 
altering the quality of results.  The pellets were re-suspended in isotonic buffer and nuclei 
isolated using Dounce homogenizer washed and lysed in SDS lysis buffer (1% SDS, 10 
mM EDTA, 50 mM Tris-HCl, pH 8.0) for 10’-1h. The lysate was then diluted three-fold 
with ChIP dilution buffer (0.01% SDS, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.0, 167 
mM NaCl, 1 mM DTT, 0.4 mM PMSF, and protease inhibitors) and ½ of chromatin (420 
µl) was sonicated using Misonix 4000 sonicator at following settings: Amp 3, 10 
consecutive cycles of 30’’ sonication each with 1’ pause in between. Triton X was added 
to the sonicated material to a final concentration of ~1%, chromatin was cleared by 
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centrifugation, diluted 3-4 times with ChIP Dilution Buffer w/1.1% Triton X-100 and 
was distributed between 2-3 antibody/bead complexes (400µl each) and incubated ON at 
4°C. 50µl of the chromatin preparation was conserved at -80°C as the input fraction. 
Antibody/magnetic beads were prepared as per Young protocol 
(http://openwetware.org/wiki/ChIP). Post-immunoprecipitation washes were performed 
using RIPA wash buffer (50 mM Hepes-KOH, pH 7.6, 500 mM LiCl, 1mM EDTA, 1% 
NP-40, 0.7% Na-Deoxycholate). The complexes were then washed with Tris-
EDTA/NaCl (10 mM Tris-HCl, 1 mM EDTA pH 8.0, 50 mM NaCl) for 5’ and 
transferred to a new chilled tube, prior to last separation (Dahl and Collas 2008). The 
chromatin was eluted in elution buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 
8.0) and cross-link reversed overnight by incubation at 65°C. The samples were 
consecutively treated with RNase A (0.2mg/ml) and then Proteinase K (0.2 mg/ml), 
extracted with phenol/chloroform/isoamyl alcohol, precipitated and resuspended in 50µl 
of 10mM Tris pH 8.0. Real-time PCR reactions were performed in a 96-well plate 
ABI7000 QPCR machine. Reactions were set up using SybrGreen (Biorad), 450µM of 
each forward and reverse primer and 1µl of each ChIP reaction or 1:100-200 dilution of 
Input fraction. The ΔΔCt method was used for quantification and calculations performed 
according to ChIP-qPCR Data Analysis instructions (SupperArray, Bioscience 
Corporation). In order to select suitable negative control primers, large regions 
(potentially corresponding to genomic deserts) of chromosome 1 were surveyed. Because 
Ets1 binding sites are present in large proportion of the chicken genome. non-specific 
binding was a concern; therefore, 8-10 different sets of primers were tested. The primers 
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presented in Fig. 6M corresponding to Sox10E2 fragment were: Sox10E2_1 for 5'-
TGCTCCTGCTGCTTATCA-3'; Sox10E2_1 rev 5'-ATCAGCTCCACTGCACAT-3'; 
Sox10E2_2 for 5'-TGATAAGCAGCAGGAGCA-3'; Sox10E2_2 rev 5'-
TGAGCAGGTTGCTGTGGAAA-3'. Control primer sets that amplify negative control 
region situated on the same chromosome as Sox10 locus were as follow: negcont_1 for 
5'-TCGGATTTTAATGGGCTCAG-3'; negcont_1 rev 5'-
CCGCAGATAGTTCTGCATCA-3' negcont_2 for 5'-GGTTGGATTTCCAGTCTCCA-
3’; negcont_2 rev 5'-TGTTTTGCTGGACAATCTGC-3’.  
 
EMSA and pull-down assays 
Five Sox10E2 subfragments (M2, M4, M8, M9, M11/M12) and three control 
fragments were obtained by annealing synthetic oligonucleotides with or without 5’ biotin 
modification (IDT Biotechnology). Double stranded fragments used in EMSA assay either 
had biotin tags on both ends or were not labeled (cold probes).  
The sequences of Sox10E2 subfragments used in these approaches were:  
M2,GCAATTTAACCTACAACTGCTGAGCTTGTA;  
M4,GGCGACTGTGCTTCCGGCTGGGGCAGTG; 
M8,GGAGCAGGGAAACAATAGGTGATTT; 
M9,TGGCCAGAGAGGAAATTGGGGGTTT; 
M11/12,CAGGGCACAAAGGCCCAACTG.  
The sequences of scrambled controls were selected based on the absence of binding 
sites with homology of greater than 70%, according to an exhaustive survey of Jaspar and 
Transfac databases. They were as follows:  
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MybCo,TCTTCAAGTCCGCCATGCCCGAAGG;  
Sox9Co,TACGGCAAGCTGTTCATCTGCACCA;  
Ets1 Co, ATGTCTACGTCGAGCGCGACGGCGA. 
EMSA. Nuclear extracts from chicken embryonic transfected with corresponding 
expression plasmids (Sox9- Ets1-, cMyb- or control-pCI H2BRFP) were obtained using 
standard hypotonic buffer (10mM HEPES pH7.9, 1.5mM MgCl2, 10mM KCl, 0.5 mM 
DTT, 1X Complete EDTA-Free Protease Inhibitors, 0.2 mM PMSF) to isolate the nuclei 
and extraction buffer (20 mM HEPES pH7.9, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM 
EDTA, 25% (v/v) glycerol, 1mM DTT, 1X Complete EDTA-Free Protease Inhibitors) to 
obtain nuclear extracts. Binding reactions and gel shift detection was performed using 
LightShift Chemiluminescent EMSA Kit (Thermo Fisher Scientific, Rockford, IL) 
following manufacturer’s instructions.  
PULL-DOWN ASSAYS. DNA fragments used in streptavidin-biotin pull-down 
assays carried a single biotin tag. Dynal streptavidin beads (Invitrogen) were coated 
according to manufacturer’s instructions, using equimolar quantities of the fragment 
labeled on either 5’ or 3’ end. 400-500 µg of embryonic nuclear proteins (extracted from 
cephalic regions of chicken embryos at stage HH9-HH12) in final volume of ~800µl of 
binding buffer (12%glycerol, 12 mM HEPES pH 7.9, 4 mM Tris pH 7.9, 150 mM KCl, 1 
mM EDTA, 1 mM DTE, and 0.1µg/µl poly(dI-dC).  These were pre-exhausted using 
~1.5mg of streptavidin Dynal beads and distributed among 4 Dynal bead preps: 2 coated 
with specific DNA fragment, one with scrambled control and one without DNA. Binding 
reactions were allowed to proceed for 30’ at RT, and were subsequently washed 4 times 
with the binding buffer (only 1st wash contained poly(dI-dC)). After the 4th wash, the beads 
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were transferred to a new tube, bound proteins eluted in 30 µl of 50mM Tris pH 7.5, 
100mM NaCl, 5mM EDTA, 1X Protease Inhibitors, 0.1% SDS and analyzed by Western 
blot using Sox9, Ets1 and cMyb antibodies. 
 
 
 
Cell death and proliferation assays 
HISTOLOGY. Embryos electroporated unilaterally with single or triple morpholino 
(@3mM concentration) were fixed in 4% paraformaldehyde and dehydrated to 100% 
methanol. After re-hydration, embryos were cryoprotected in 15% sucrose, equilibrated in 
15% sucrose/7.5% gelatin, embedded in 20% gelatin and sectioned at 10 µm using Micron 
cryostat.  
TUNEL REACTION. The slides were first washed twice in PBS at 42oC for 10’ to 
remove gelatin, followed by 3-4 10’ washes in PBST (PBS+ 0.5% Triton X-100) at RT. 
After 10’ incubation in Permeabilization solution (0.1% sodium Citrate, 0.5% Triton in 
PBS) and two PBST rinses, the slides were incubated in Tunel reaction mix (In Situ Cell 
Death Detection Kit, TMR red, Roche). Labeling solution was first diluted 10 times with 
Tunel buffer (30 mM Tris pH 7.2, 140 mM Sodium cacodylate, 1 mM CoCl2) and then 
combined with enzyme mix as per manufacturer’s instructions (1 part enzyme + 9 parts 
label). A positive control slide, pre-treated with DNAse I (2µl of 10U/µl stock in 100µl of 
DNase buffer: 10mM CaCl2, 40mM Tris Cl pH7.4, 10mM MgCl2, 10mM NaCl, for 1h at 
RT) was prepared in advance, rinsed with 2mM EDTA in PBST to quench DNase activity, 
washed twice in PBST and stained with Tunel reaction mix as well. Negative control slide 
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was incubated in tunel labeling mix, without TdT enzyme. The labeling was performed in 
the dark, for 4 h in a humidified chamber at 37°C. The slides were then washed 3x PBST 
for at least 15 min each time, the positive control slide was rinsed in a separate container.  
IMMUNOSTAINING. The slides were incubated in blocking buffer (10% donkey 
serum in PBST) for 1 hour followed by primary antibodies diluted in blocking buffer 
overnight at 4oC, (1:1000 rabbit antiPh3 (Phospho-Histone 3) and 1:800 Alexa 488 goat 
anti FITC). Slides were then rinsed 3-4 times in PBST, 30 min each wash. Secondary 
antibody was diluted in PBST or blocking buffer and applied for 1 hour at RT. As the 
TUNEL staining is red (TMR red), we used 1:1000 Alexa 350 goat anti-Rabbit (blue) to 
detect antiPh3 and FITC (morpholino) was labeled in green. All consecutive sections from 
the cranial region were counted and number of Ph3- (and Tunel-) positive cells within the 
neural fold was compared between morpholinoated and control sides for individual, triple 
and control morpholinos. We present the mean value of electroporated/control side ratio for 
triple and control morpholinos. The statistical values were calculated using unpaired 
student’s t-test. 
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Figure 1. Sox10 cis-regulatory analysis. (A) Schematic diagram showing comparative 
genomic analysis using ECR browser. Chicken, zebrafish, Xenopus, opossum, mouse, rat 
and human genomic sequences were compared between Sox10 and neighboring genes, 
Slc16A8 and PolR2F. Red peaks = highly conserved elements; blue = coding exons; green 
= transposable elements and simple repeats. Boxed Sox10 putative regulatory regions L8(L 
= late) and E(E = early) show activity in neural crest. UTRs shaded in yellow. (B) At 
HH8+, GFP transcripts are detected by fluorescent in situ hybridization in cranial neural 
crest (CNC) similar to endogenous Sox10 expression(G). Distribution of EGFP transcripts 
(C, D, E; HH9+, 12, 15) is similar to endogenous Sox10 in H-J, respectively. (D) EGFP 
expression at HH12 in rhombomere5 stream surrounding otic vesicle (OV) resembles 
endogenous Sox10 (I), but is missing in vagal neural crest (VNC). (F) Cross section of 
embryo in D shows specific Sox10E regulatory activity in CNC around optic vesicle 
(OpV). (G-J) Endogenous Sox10 expression at HH8+-15. OP, otic placode. 
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Figure 2. Sox10E contains distinct spatiotemporal regulatory elements: Sox10E2 in 
delaminating CNC and Sox10E1 in later migrating vagal (VNC) and trunk neural 
crest. (A) Schematic diagram representing dissection of Sox10E fragment, located ~1kb 
downstream of Sox10 locus (UTR in yellow). Two smaller active regulatory fragments 
embedded within Sox10E (Sox10E1&E2) each contain a conserved region (red bar) with 
70% sequence homology between amniotes. (B) Sox10E2 drives expression in 
delaminating CNC (arrows) at HH8+; Sox10E1 is first active in migrating VNC at HH15 
(C). (D) Sox10E1 activity persists in migrating VNC, trunk neural crest (arrow), and 
branchial arches 3-5 (arrowhead). (E) Table1 summarizes distinct temporal (HH9-18) and 
spatial (cranial/vagal/trunk) regulatory activity of Sox10E1, E2. Red - = no expression; 
green + = EGFP reporter expression. 
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Supplementary Figure 1. Dissection of the Sox10E2 fragment reveals an essential core 
and auxiliary region important for optimal enhancer activity. (a) “Zoomed in” image 
showing the region Sox10E2 from the genomic comparative analysis illustrated in Fig. 2A. 
Each uncolored peak represents the conserved region equivalent to region Sox10E2 in 
chicken for each corresponding species. Inside the conserved regions, the red patches 
represent highly conserve portions (85%-90% each 30bp). The order of species from top to 
bottom: mouse, dog, opossum, rat, chimpanzee and human. 
(b) Schematic diagram representing the different successive deletions (dotted lines) that 
were performed, guided by bioinformatics, to identify the main core element responsible 
for the regulatory activity of the Sox10E2 fragment. The horizontal black lines represent 
different fragments. Red portion of the lines denote a 160bp region (referred to as essential 
core element), highly conserved between dog, chimpanzee and human, capable of 
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producing weak tissue-specific regulatory activity in delaminating cranial neural crest cells. 
The gray arrow points to a non-conserved 59bp-long auxiliary region, necessary for 
achieving strong regulatory activity of the enhancer. CNC, cranial neural crest.  
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Supplementary Figure 2. Dissection of Sox10E reveals two regulatory regions that 
function in a specific spatiotemporal manner: Sox10E2 is activated as cranial neural 
crest cells delaminate whereas Sox10E1 is activated in later migrating vagal and 
trunk neural crest. (a) Sox10E1 displays no activity in the delaminating cranial neural 
crest. (b) Sox10E2 activity at HH15 persists in the periocular crest and otic vesicle, but also 
within the first two branchial arches, which lack endogenous Sox10; Sox10E2 is not 
expressed in vagal neural crest at this stage or later, at HH18 (c) in either the vagal or trunk 
regions. (d-f) Panels corresponding to a-c, respectively, show expression of the co-
electroporated tracer pCI H2B-RFP to locate cells that received both tracer and reporter 
EGFP plasmid DNA.  
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Figure 3. Transcriptional inputs into the Sox10E2 regulatory region. (A) Schematic 
diagram showing sequence alignment of 264bp Sox10E2 regulatory region; essential core 
80 
 
region shaded in yellow. Colored frames indicate computationally identified putative 
transcription factors binding motifs. Mutations M1-M13 were replaced by random 
sequences. Faded sequence shows a 45bp region deleted or replaced by mCherry coding 
sequence. Highlighted in blue are conserved nucleotides within putative binding motifs. 
Single dashed lines indicate no bases in aligned sequence. Thick dashed lines indicate 
nonalignable sequences. Thick solid underlines delineate Sox10E2 subfragments used in 
EMSA and pulldown assays. Sox10E2-driven EGFP expression in CNC (B) is abolished 
upon mutation of an Ets1 binding motif (C), but only decreased after mutation of putative 
SoxD motif (D), and not affected by simultaneous mutation of four putative Pax sites (E). 
(F) Simultaneous inactivation of SoxE, Ets and Myb binding sites (M2, M8, M9, M11, 
M12) within a much larger genomic region abolishes reporter expression in delaminating 
CNC. 
 
 
 
 
 
 
 
 
 
 
 
 
81 
 
 
 
 
Supplementary Figure 3. Transcriptional inputs into the Sox10E2 regulatory region. 
(a) EGFP pattern of expression in neural crest cells driven by the intact Sox10E2 regulatory 
region (b, c). EGFP expression (b, green) is abolished in cranial neural crest when binding 
motifs for putative upstream regulators, SoxE (b) and a pair of Myb (c), are mutated 
(mutations M8, M2/M12 respectively). (d) A mutation of a single Myb binding site mildly 
decreases EGFP reporter expression while a NFkB1 mutation does not affect reporter 
signal (e).   
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Figure 4. Ets1 and cMyb transcription factors are necessary for activation of Sox10E2 
regulatory element. (A) Control morpholino(right; red) has not effect on Sox10E2-driven 
Cherry (B; green) compared to non-electroporated (left) side. cMyb MO (D) significantly 
reduces, whereas Ets1 MO (G) abolishes Sox10E2-driven Cherry expression, (E,H, 
respectively; C, F, I are merged images of A/B, D/E and G/H, respectively). White dotted 
lines = midline. Green/red channels inverted for consistency. (J-L) Endogenous cMyb, Sox9 
and Ets1 expression precedes that of Sox10, consistent with being upstream regulators. At 
HH6, cMyb is expressed within the neural plate border (J) and confined to dorsal neural 
folds containing CNC by HH8 (K;K’; arrowheads). At HH10, cMyb is observed in 
migrating neural crest (L and section at dotted line, L’ arrows). At HH8, prior to Sox10 
onset, Sox9 (M) and Ets1 (N) are expressed by presumptive cranial neural crest in the 
dorsal neural tube.  
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Supplementary Figure 4. Morpholino-mediated Sox9 knock-down significantly 
reduces Sox10E2 regulatory activity. (a) FITC-labeled control morpholino (in red) does 
not affect Sox10E2 driven Cherry expression (in green) (b). (c) Merged image of a and b 
shows overlap of control morpholino (in red) with Sox10E2 driving expression of Cherry 
(in green). (d) Sox9 FITC-labeled morpholino (in red) strongly reduces Sox10E2 driven 
Cherry expression (in green, white arrow) (e). (f) Merged image of d and e shows the effect 
of Sox9 morpholino (in red) on reporter expression of Cherry driven by Sox10E2 
regulatory region (green). Embryos were electroporated on the right side only. The images 
were pseudo-colored using Photoshop, with green and red channels inverted for 
consistency, indicative of reporter expression. 
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Figure 5. Sox9, cMyb and Ets1 are required for endogenous Sox10 expression in 
delaminating neural crest cells. HH8+ embryos with unilateral electroporation of Sox9 
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(A, E), cMyb (B, F) and Ets1 (C, G) morpholinos (MO; green) show significant decrease in 
endogenous Sox10 expression in delaminating CNC compared to non-electroporated side, 
whereas control MO (L, M) has no effect. Co-electroporation of Sox9,cMyb,Ets1 MOs 
completely abolishes endogenous Sox10 expression (D, H). Showing specificity, the effect 
is rescued by co-electroporation with corresponding expression construct: Sox9 MO+Sox9 
DNA (I), cMyb MO+cMyb DNA (J) or Ets1 MO+Ets1 DNA (K). Statistical relevance by 
chi-squared test of MOs on Sox10 expression was p<0.02; of rescues was 
p<0.03(Sox9;Ets1) and p≤0.04(cMyb).  
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Supplementary Figure 5. Electroporation of Ets1, cMyb, Sox9 and control 
morpholinos does not affect cell proliferation and does not induce apoptotic cell 
death. Embryos electroporated with FITC-labeled triple (Ets1, cMyb and Sox9) or control 
morpholinos (a, b) were sectioned and with TUNEL staining (c, d) or anti-Phospho-Histone 
H3 (Ph3) antibody staining (e, f) was performed on sections. (g, h) Overlay of FITC, 
TUNEL and Ph3 staining presented in (a, c, e) and (b, d, f), respectively. All consecutive 
sections from the cranial region were counted and number of Ph3- (and Tunel-) positive 
cells within the neural fold was compared between morpholino-ed and control sides. Mean 
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value and standard deviation of electroporated/control side ratio from 4 independent 
embryos are presented (i, TUNEL, green bars; j, Ph3, blue bars). The statistical calculations 
performed using unpaired student’s t-test show no statistically significant differences in cell 
death or proliferation counts between electroporated and control sides of embryos receiving 
either three specific morpholinos or control(@3mM). 
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Figure 6. Sox9, cMyb and Ets1 overexpression ectopically induces Sox10E2 
regulatory activity. EGFP is observed in migrating crest and otic vesicle (OV) when 
Sox10E2-EGFP is co-electroporated with control plasmid, pCI H2B-RFP. (A, F) 
overexpression of either Sox9 (B, G), Ets1 (C, H) or cMyb (D, I) ectopically activates 
Sox10E2-driven EGFP expression in extraembryonic ectoderm (white arrows). In (H) 
arrowheads show EGFP expression in posterior neural tube. Misexpression of Ets1 (E) fails 
to activate ectopic EGFP expression (J, arrows) in mutated Sox10E2 construct lacking an 
Ets binding motif (M9). (K) EMSA shows a clear band shift (white arrowhead) when 
nuclear extracts containing overexpressed Sox9, Ets1 or cMyb proteins are combined with 
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Sox10E2 subfragments, M11, M9 and M2, respectively (1st lane). This binding is 
outcompeted when excess non-labeled probe is added (2nd lane) and absent from nuclear 
extracts from control plasmid-transfected cells (3rd lane). (L) Biotinylated Sox10E2 
subfragments (M8, M11-Sox9, M4, M9-Ets1 and M2, M12-cMyb), as well as scrambled 
control fragments and non-coated Dynal streptavidin beads, used as bait in a DNA 
pulldown assay show specific transcription factor binding as analyzed on a Western blot. 
(M) Direct binding of Ets1, cMyb and Sox9 to the Sox10E2 enhancer element in vivo as 
assessed by qChIP. Binding to Sox10E2 (red bars) or control region (grey bars) was 
assessed with two primer sets for each region and expressed as relative enrichment of target 
over control antibody; graph reflects mean +SD from a representative experiment. qChIP 
was performed 3-4 times for each factor.  
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Supplementary Figure 6.  Binding motifs for SoxE, Ets and Myb within Sox10E2 
enhancer need to be functional in order for ectopic reporter expression to occur when 
misexpressing Sox9, cMyb and/or Ets1, individually or in combination. 
(a, d) Ectopic EGFP expression is observed in the extraembryonic region, ectoderm cells 
(arrowheads) and along the neural tube (d), when Sox9-pCI H2B-RFP, Ets1-pCI H2B-RFP 
and cMyb-pCI H2B-RFP (red) are simultaneously over-expressed (a). Combined Sox9 and 
cMyb misexpression (b) fail to activate ectopic EGFP expression through a mutated 
Sox10E2 regulatory region (M9) that lacks an Ets binding motif (e), whereas, 
overexpressing Sox9 and Ets1 simultaneously can activate weak reporter expression 
(arrows) through a mutated Sox10E2 lacking one Myb (M12) binding motif.  
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C h a p t e r  3  
cMyb, Sox8 and Pea3 Regulate the Onset of Sox10 Expression 
by Converging on Enhancer Sox10E2 in the Otic Placode 
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Abstract 
 
The otic placode, a specialized region of embryonic ectoderm, gives rise to the 
components of the inner ear, including semicircular canals, cochlea, an endolymphatic 
duct, as well as supporting and hair cells that form the sensory epithelium. In the gastrula 
stage embryo, placode and neural crest precursors are found at the neural plate border 
between the future epidermis and neural plate. Later, presumptive neural crest cells occupy 
the dorsal margins of the closing neural tube whereas placode cells come to reside outside 
of the neural plate in the patches of thickened ectoderm that comprise olfactory, trigeminal, 
otic and epibranchial placodes.  The enhancer Sox10E2 has regulatory activity in both 
cranial neural crest and otic placode cells.  Here, I demonstrate that three transcription 
factors mediate Sox10E2 expression in the otic placode region.  cMyb, Sox8 and Pea3 are 
all necessary for the initial otic Sox10 expression and mutating each of the corresponding 
binding motifs within the enhancer, greatly reduces enhancer activity in the ear. These data 
establish new regulatory connections and uncover a new function for cMyb in the 
development of the otic placode.  
 
 
Introduction 
 
Placodes are defined as thickened regions of cranial ectoderm that delaminate or 
invaginate from the surface ectoderm and migrate into the adjacent mesenchyme (Schlosser 
2008). Placodal cells contribute to the formation of the lens of the eye, sensory structures in 
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the ear and olfactory epithelium as well as cranial ganglia. The best studied cranial placode 
is the otic placode, which thickens from the ectoderm adjacent to rhombomeres 5 and 6 
(Hogan and Wright 1992). In chicken embryos, otic placode is first visible at stages HH9-
10, then invaginates and separates from the surface ectoderm to form the otic vesicle, and 
later undergoes complex morphogenetic rearrangements to generate components of the 
inner ear (Dutton K. et al. 2009).  Like neural crest cells, the otic placode expresses 
members of the SoxE family of transcription factors, Sox8, Sox9 and Sox10. As described 
in Chapter 1, the transcription factors Sox9 and Sox10 play important roles during neural 
crest cell specification, migration and differentiation. In particular, Sox10 plays a critical 
role in many aspects of neural crest development, from migration to differentiation.  In 
contrast, not much is known about the function of SoxE genes in the otic placode.  SoxE 
mutations such as those observed in Wardenburg syndrome type IV lead to defects in the 
ear.  These defects, were previously attributed to a reduction in the number of melanocytes 
contributing to the ear (Bondurand et al. 2007) or cells that form glial cells of the spiral and 
vestibular ganglia (gVIII) (Evans and Noden 2006), both neural crest cell derivatives 
characterized by the expression of Sox10. However, recently it was noted that Sox8, Sox9 
and Sox10 also are expressed in the otic epithelium, suggesting that SoxE genes have a 
more direct role in the development of the inner ear (Chiang et al. 2001, Dutton K. A. et al. 
2001, O'Donnell et al. 2006).  
In Xenopus, Sox9 has been reported to be involved in the invagination of the otic, 
based on the observation that Sox9 morphant placodes do not attach to the neural tube, fail 
to invaginate and undergo apoptosis (Barrionuevo et al. 2008). In zebrafish, Sox9b deletion 
mutants show a slightly small ear while double mutants for Sox9a and Sox9b lack or have 
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vestigial otic vesicles, due to a failure in the otic placode induction (Liu D. et al. 2003, Yan 
et al. 2005). The differences in Sox9 loss-of-function effects observed in zebrafish versus 
Xenopus may be due to differences in otic formation between the two different species. In 
zebrafish, rather than invagination, the formation of the otic cup involves cavitation. 
Similar to Sox9 mutants, zebrafish sox10 mutants display subtle vesicle shape defects.  At 
later stages, the size of the vesicle is smaller than normal, due partially to cell death (Dutton 
K. et al. 2009). A role for Sox9 and Sox10 in cell survival and maintenance of 
multipotency in the otic placode is not surprising given its similar previously demonstrated 
functions in neural crest cells (see Chapter 1). Just as in the neural crest, there appear to be 
cross-regulatory interrelationships among SoxE genes during ear development. For 
instance, de-repression of Sox9 is observed in zebrafish Sox10 mutants, while maintenance 
of Sox10 expression throughout otic epithelia development depends upon SoxE function. 
Mutating Sox10 and simultaneously knocking down sox9a and b is sufficient to greatly 
disrupt Sox10 expression (Dutton K. et al. 2009). Nevertheless, these gene perturbations do 
not completely eliminate Sox10 expression, suggesting that other factors, such as Sox8, 
also may be involved in the regulation of Sox10.  
As opposed to maintenance of expression, less is known about what regulates onset 
of any of the SoxE genes. To tackle this question, I took advantage of the previously 
identified Sox10E2 enhancer and its regulatory activity in the otic, to probe for the 
upstream factors that regulate initial Sox10 expression in this region. Interestingly, 
mutational analysis revealed that the same binding motifs within Sox10E2 that function in 
neural crest cells, are also required for the initial activity of the enhancer in the otic 
placode. However, a different set of activators mediate the enhancing activity of Sox10E2, 
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most likely through the interaction with these essential binding sites.  These results show 
that cMyb together with two other factors the Ets family member, Pea3, and the SoxE 
family member, Sox8, are necessary for the initial endogenous expression of Sox10. Thus 
these data suggest a dual conserved role for the enhancer Sox10E2 in initial regulation of 
Sox10 expression both in cranial neural crest cells and otic placode cells.   
 
 
Results 
 
Three core Sox10 enhancers: Sox10L8, Sox10E1 and Sox10E2 have regulatory activity 
in the forming otic placode and vesicle 
The identification, isolation and cloning of the three Sox10 regulatory regions 
Sox10L8, Sox10E1 and Sox10E2, have been previously described (see Chapter 2). Each 
genomic fragment was tested for regulatory activity by electroporating the whole epiblast 
of chicken embryos at stage HH4. Embryos electroporated with the plasmid containing the 
enhancer Sox10E2 (2.1kb downstream Sox10) first exhibited EGFP reporter expression at 
stage HH9+ coincident with the onset of Sox10 endogenous expression in the forming otic 
placode (Chapter 2, fig. 1C-E, H-J). On the other hand, weak EGFP reporter activity was 
observed later, at the otic vesicle stage, in the case of the two other Sox10 regulatory 
regions Sox10L8 (6.1Kb upstream) and Sox10E1 (1.1kb downstream) (Chapter 5, Table1). 
Thus Sox10E2 is the only identified enhancer that mediates reporter expression with the 
first appearance of endogenous Sox10 expression in the otic placode.   
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Binding motifs for SoxE, Myb and Ets transcription factors are required for strong 
enhancing activity of Sox10E2 in the developing otic placode 
Previously I demonstrated that a 264 core regulatory region, Sox10E2, was 
fundamental for the initial activation of Sox10 expression in the cranial neural crest  
(Chapter 2, fig. 2A & B, Table1 on Fig2E). To test its function in the otic placode, careful 
dissection of the 264 bp fragment was performed by cutting around and through a highly 
conserve region (HCR) of ~160bp in length. Regulatory activity of each subfragment was 
tested by electroporating each plasmid version at stage HH4. Initial dissections showed that 
a 138bp fragment containing a portion of the 160bp HCR plus some sequence at the 3’ end 
was sufficient to activate weak reporter expression. The 160bp HCR by itself was also able 
to drive weak EGFP expression while the 5’ portion of Sox10E2 flanking a portion of the 
160bp HCR failed to promote regulatory activity (Fig. 1). These results suggest that the 
minimal binding motifs required for basal activity of the enhancer in the otic placode were 
contained in the 3’ portion of Sox10E2.  Furthermore, Sox10E2 appears to contain many 
dispersed functional binding motifs, some of which are located in the 5’ end, and are 
required for the strong enhancing activity. This experimental information was coupled with 
bioinformatics to recognize potential transcription factor binding motifs in order to locate 
possible inputs important for otic placode formation. Detailed mutational analysis showed 
that mutating two Myb, either SoxE, or one Ets sites significantly decreased EGFP reporter 
activity in the otic while the mutation of other sites such as Pax, NFKB, Elk/Ets or SoxD 
sites had no effect, when compared to embryos that received the construct carrying an 
intact Sox10E2 (Fig. 1 and Figs. 2A-H). Furthermore, a fragment containing an Ets site 
alone was not sufficient to regulate weak reporter expression (Fig. 1), suggesting that a 
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single Ets factor was not sufficient to account for initial Sox10 expression. Dissection and 
mutational results demonstrated that a minimal fragment containing a single SoxE and one 
Ets is sufficient to activate weak expression of EGFP (Fig. 1).  The addition of a second 
SoxE and a single Myb functional site leads to recovery of strong expression of EGFP (Fig. 
1). Interestingly, the simultaneous mutation of the five Myb, SoxE and Ets functional 
binding motifs (Fig. 1) in a larger genomic context that included enhancer SoxE1 
eliminated reporter expression at early stages HH9+ through HH13 (Figs. 3A, B).  There 
was only residual and scattered EGFP expression beginning to appear around stage HH13 
(Fig. 3B) and weak reporter activity observed at stage HH15 (Fig. 3C), resembling the 
activity produced by enhancer Sox10E1 only after the otic vesicle has formed. This 
demonstrates that these five binding motifs are essential for the early regulation of Sox10 in 
the otic placode and suggests that the role of Sox10E1 in the otic placode is that of 
maintaining Sox10 expression.  
 
cMyb, Pea3 or Sox8 but not Ets2 or Sox9 reduce EGFP reporter expression by acting on 
Sox10E2  
Previously it has been shown that the transcription factors Pea3, a member of the 
Ets1 family, and Sox8 are present in the otic placode preceeding Sox10 expression, whereas 
Sox9 expression follows that of Sox10 (Bagheri-Fam et al. 2006, Lunn et al. 2007, 
McKeown et al. 2005) (Geisha ID# pgm2n.pk009.c2 for Sox8). In addition, I confirmed by 
in situ hybridization that cMyb is present at stage HH9, just as Sox10 transcripts begin to 
appear around the otic placode (Fig. 4A). Similarly, Ets2 is present in the forming otic 
placode just prior to Sox10 and continues to be expressed at stage HH9+ (Figs. 4B, C & 
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C’). These expression studies are consistent with the possibility that cMyb, Pea3, Ets2, 
Sox8 and/or Sox9, are candidates for mediating Sox10 expression in the otic plaocode via 
Sox10E2.  To test this possibility, I designed morpholino antisense oligonucleotides to 
specifically knock down each factor and examined the subsequent effects on the Sox10E2 
regulatory activity. Since Sox10 is expressed prior Sox9 in otic placode, my prediction was 
that Sox9 would not affect Sox10 expression in early stages of otic placode development, 
whereas expression of the other transcription factors preceeds that of Sox10. After 
morpholino electroporations, embryos treated with cMyb, Pea3 or Sox8 morpholinos had a 
significant reduction of reporter signal driven by Sox10E2 enhancer (Figs. 5J-R) when 
compared to embryos treated with control (Figs. 5A-C). In contrast, little or no effect was 
noted with morpholino against either Sox9 or Ets2 (Figs. 5D-I).  The results are consistent 
with the possibility that cMyb, Pea3 or Sox8 regulate Sox10 expression through their 
corresponding functional SoxE, Ets and Myb binding motifs within the Sox10E2 regulatory 
region.  
 
Endogenous Sox10 expression is reduced in the otic placode when either cMyb, Pea3 or 
Sox8 are knock down 
Since reporter signal under the control of Sox10E2 enhancer was reduced in the 
presence of morpholinos against cMyb, Sox8 or Pea3, I next investigated if these 
perturbations have an effect on endogenous Sox10 expression.  Knocking down cMyb 
(Figs. 6C, D), Pea3 (Figs. 6E, F) or Sox8 (Figs. 6O, P) significantly reduced Sox10 
expression in embryos analyzed at stage HH11 and later at stage HH13 (Figs. 6J-M,  S, T). 
In contrast, embryos electroporated with control morpholino (Figs. 6A, B) or Ets2 (Fig. 
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6G) showed no effect on Sox10 expression (Figs. 6H, I & N).  To check if the effect caused 
by morpholino electroporations was a specific reduction in Sox10 transcripts, I used a 
preplacodal marker, Pax2 to immunostain embryos that were treated with Pea3 
morpholino. There was no significant change in Pax2 expression on the morpholino 
electroporate compared with contralateral side (Figs. 6d-f) and embryos treated with 
control morpholino (Figs. 6a-c), confirming that the observed reduction was due to 
reduction in Sox10 transcripts rather than secondary effects. 
While individual knock down of each candidate factor reduced early Sox10 
expression, it was not abolished. However, simultaneous knock-down by electroporating 
morpholinos against all three (Figs. 6Q, R) completely eliminated Sox10 expression at 
stage HH11 (Fig. 6U) and resulted in reduced expression at stage 13 (Fig. 6V). These 
results agree with the results obtained when mutating the binding sites for Myb Ets and 
SoxE in a larger genomic fragment containing Sox10E2 and Sox10E1 enhancers. The later 
recovery of endogenous Sox10 expression may be due to the regulatory activity of other 
enhancers found in Sox10 genomic locus including, perhaps, Sox10E1.  
 
Discussion 
 
A 264bp downstream Sox10 enhancer is sufficient to regulate gene expression in the 
forming otic placode 
In the early chick embryo, I have identified three Sox10 genomic fragments, 
Sox10L8, Sox10E1 and Sox10E2, which had regulatory function in the developing otic 
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region. This study shows that the onset of regulatory activity of one of the identified 
fragments, Sox10E2, correlates with the onset of endogenous Sox10 expression in the 
forming otic placode, while the activity of the other two regulatory regions appeared 
approximately 10 hrs later.  This suggests that the Sox10E2 enhancer is responsible for 
initiation of Sox10 expression in the otic region, whereas Sox10L8 and Sox10E1 and 
probably other unidentified regulatory regions are recruited to maintain Sox10 expression 
in later ear development. Because reporter signal was much brighter for Sox10E2 than the 
other two regulatory fragments, These results suggest that Sox10E2 may play a primary 
role in the regulation of Sox10 in the ear and the other fragments may have supporting 
roles. For example, Sox10L8 and Sox10E1 might function synergistically as supporting 
elements, since they are both active and exhibit weak expression at later stages (~stg 13), 
when the otic vesicle is beginning to take shape. 
 I previously demonstrated that 264bp enhancer Sox10E2 is necessary for initial  
Sox10 expression in the nascent cranial neural crest (Betancur et al. 2010), albeit with 
different, paralogous inputs. That the same Sox10 regulatory region functions in two 
different cell populations--the cranial crest cells and placode cells—points to either 
common evolutionary ancestry or functional cooption between the two populations.  
 
Characterization of Sox10E2 reveals critical binding motifs including two Myb, two 
SoxE and one Ets site required for strong activitation in the otic placode 
Systematic deletion of portions within the 264bp enhancer Sox10E2 allowed 
identification of regions necessary for the strong enhancing activity. An HCR within the 
Sox10E2 sequence together with a ~33bp to the 3’ end of the HCR were sufficient to 
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activate strong reporter expression in the otic. In contrast, activity was weakened if the 
33bp tail to the 3’end of the HCR was deleted regardless the presence of 38bp tail upstream 
of the HCR. Thus, it could be conclude that essential motifs responsible for the strong 
activity of the enhancer, are distributed along the highly conserved region and the non-
conserved 3’ end tail.  Mutational analysis revealed that SoxE, Ets and either one of two 
Myb binding motifs, which I previously found to be necessary for the expression of 
Sox10E2 reporter in neural crest cells, are also employed for the strong activation of 
Sox10E2 in the otic placode. However, analysis of reporter expression in these cells 
revealed that each individual mutated motif, including a double myb mutation, decreased 
reporter signal intensity rather than completely abolishing the regulatory activity of 
Sox10E2 as was the case for neural crest cells. Therefore, I concluded that in the placodal 
region, each binding motif contributes to the enhancing activity of the regulatory region, 
albeit none is individually necessary. Rather, it is the cluster formed by the two SoxE, the 
Ets and either one Myb site that is sufficient for the strong activity of the enhancer during 
early Sox10 expression in the otic placode. I also observed that the simultaneous mutation 
of all sites within the Sox10E2 region contained in a 3.5kb genomic fragment that also 
includes enhancer Sox10E1, delayed reporter expression until stage HH13, demonstrating 
that this cluster of binding motifs is necessary for initiation of Sox10E2 enhancer 
regulatory activity in the placode cells, whereas Sox10E1, regulates gene expression at later 
stages.  
As opposed to neural crest cells, Sox10E2 in placodal cells seems to have basal  
regulatory activity that is not affected by individual mutation of Ets or SoxE sites or by the 
double mutation of Myb sites. In only one case, a fragment containing one Myb and one 
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SoxE but lacking the Ets and 3’ end SoxE sites had no regulatory activity.   Basal activity is 
restored when the fragment contains the functional Ets coupled with either SoxE functional 
sites. However, a small fragment containing only the Ets site fails to activate reporter 
activity (Fig. 1, orange fragment), confirming that the presence of other motifs, is required 
for basal activity of the regulatory region. Taken together, the results suggest that as long as 
one SoxE and the Ets site are present, Sox10E2 can produce basal regulatory activity that is 
enhanced when either Myb site is present.  
 
cMyb, Pea3 or Sox8 control Sox10 expression through its identified regulatory region 
Sox10E2 
In this study, I show that cMyb expression precedes that of Sox10 in the otic  
placode, making it a good candidate to mediate the onset of Sox10 expression. Morpholino 
perturbation of cMyb revealed that it is necessary for strong activity of Sox10E2. In a 
previous study, I found that cMyb binds directly to the identified Myb binding motifs 
within Sox10E2 (Betancur et al. 2010) in cranial neural crest cells.  Thus, it is likely that 
cMyb can directly bind to the same sites of enhancer Sox10E2 in the otic placode cells. 
Similarly, in the same study, it was demonstrated that Sox9 or Ets1 factors in cranial neural 
crest cells bind and activate Sox10 early expression through SoxE and Ets binding sites, 
respectively, within Sox10E2. Interestingly, I find that paralogous factors, Sox8, Pea3 and 
Ets2, are expressed in the otic placode, making them potential candidates for directly 
activating Sox10E2 in the placode.  Moreover, they are expressed prior to Sox10 in the otic 
placode cells. Both Ets2 and Pea3 are able to bind to and activate similar consensus sites 
(Fisher et al. 1991, Kopp et al. 2004).  However, the morpholino studies performed here 
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demonstrate that Sox8 and Pea3 but not Ets2 knock-down reduce reporter expression 
driven by Sox10E2 enhancer in the otic placode. This suggests that Sox8 and Pea3 can 
regulate Sox10 expression through Sox10E2 regulatory region. In addition, loss-of-function 
of either cMyb, Sox8 or Pea3 reduces early expression of endogenous Sox10 and 
simultaneous knock-down of all three factors causes a complete loss of endogenous Sox10.  
This suggests that these three factors converge on the Sox10E2 regulatory region and all 
are necessary to initiate Sox10 expression in the placode cells.  
In summary, I have established that the Sox10E2 regulatory region is a dynamic 
enhancer, in which similar binding motifs are employed for regulation of Sox10 in two 
different populations of cells—the cranial neural crest and otic placode. Although SoxE, 
Ets or both Myb binding motifs enhance the activity of Sox10E2 in placodal cells, each 
motif is not completely necessary for some basal regulatory activity to occur. Importantly, I 
show that the combined action of transcription factors cMyb, Sox8 and Pea3 is required to 
initiate Sox10 gene expression, thereby uncovering a novel regulatory function for these 
factors in otic placode development. Intriguingly, different family members of the SoxE 
and Ets family mediate initiation of Sox10 expression in the neural crest by binding to the 
same motifs within Sox10E2. Thus, the function of a regulatory region has been conserved 
in two different cell populations whereas the upstream gene activators have changed.  This 
may be due to a combination of gene duplication/divergence and changes in the cis-
regulatory machinery that control the timing and spatial expression of these upstream 
factors, creating a different activating code for the Sox10 enhancer unique to each cell 
population. 
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Materials and methods 
 
Ex ovo/in ovo electroporations  
Chicken embryos were electroporated at HH4-8 to target the cranial neural crest 
and at stages HH10-12 to target vagal and/or trunk neural crest following previously 
described procedures (Sauka-Spengler and Barembaum 2008). In morpholino-mediated 
knockdown experiments, only ex-ovo electroporations were performed. Morpholinos used 
in this study were obtained from Gene Tools (Philomath, OR).   
 
Comparative genomic analyses and cloning of putative Sox10 regulatory regions 
Highly conserved genomic regions were identified using ECR browser 
(http://rvista.dcode.org/). Binding motifs were predicted using Jaspar database 
(http://jaspar.genereg.net/cgi-bin/jaspar_db.pl) and P-Match program from Transfac 
database (http://www.gene-regulation.com/pub/programs.html). Putative regulatory regions 
were amplified with Expand High Fidelity Plus (Roche, Indianapolis, IN), from chicken 
BAC DNA (BACPAC, Oakland, CA) and cloned into the ptk-EGFP vector (Uchikawa et 
al. 2003). ptk-Cherry and pCI H2B-RFP constructs were generated for this study. For 
details regarding dissection and mutations of regulatory elements see Chapter 2, Materials 
and Methods. 
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Morpholinos 
Morpholino-mediated knock-down experiments were performed by injecting the 
translation-blocking, FITC-labelled morpholino antisense oligonucleotides in one half of 
the epiblast (right to the primitive streak) embryo ex-ovo. Morpholinos used in this study 
were obtained from Gene Tools (Philomath, OR) and their sequences are as follows:  
Control_5’-ATGGCCTCGGAGCTGGAGAGCCTCA-3’; 
cMyb_5’-ATGGCCGCGAGCTCCGCGTGCAGAT-3’;  
Pea3_5′-CTGCTGGTCCACGTACCCCTTCATC-3′;  
Sox8_5’-CTCCTCGGTCATGTTGAGCATTTGG-3’; 
 Ets2_5’-GTTTCTGATCGCAAATTCACTCATC-3’; 
Sox9_5’-GGGTCTAGGAGATTCATGCGAGAAA-3’. 
 
In situ hybridization 
Whole-mount in situ hybridization was performed using a procedure previously 
described (Wilkinson 1992). Fluorescent in situ procedure using GFP probe was adapted 
from (Acloque et al. 2008).  
 
Microscopy and inmunohistochemistry 
The electroporated embryos were collected at stages HH9-15, fixed in 4% 
paraformaldehyde overnight and then washed three times in PBS at room temperature. A 
Zeiss Axioskop2 Plus fluorescence microscope equipped with the AxioVision software 
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was employed to image the embryos. Images were processed using Adobe Photoshop 
CS2. After imaging, embryos were cryo-protected in two steps: 15%sucrose/PBS and 
7.5%gelatin/15% sucrose/PBS, equilibrated and mounted in 20% gelatin/PBS and frozen 
in liquid nitrogen. 12mm cryosections were collected on Super Frost Plus slides (Fischer 
Scientific, Pittsburgh, PA) and de-gelatinized for 2 x 10 minutes at 42°C in PBS. Sections 
were subsequently washed, cover-slipped and imaged using the same imaging procedure 
described for the whole-mounts.  
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Figure 1. Analysis of reporter expression driven by different versions of enhancer 
Sox10E2 in the otic placode.  Different versions of the regulatory region Sox10E2, were 
created by dissecting the 264bp fragment into smaller fragments, cutting through or around 
the 160bp highly conserved region (dark green line), or by mutating computationally 
located binding motifs (blocks of hatched lines). Fragment versions showing strong 
regulatory activity in the otic placode are depicted in dark green, light green represents 
weak activity whereas no activity is shown in orange. Identified functional binding motifs 
are shown in lavender. 
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Figure 2. SoxE, Ets and Myb binding motifs are required for the enhancing activity of 
module Sox10E2 in the otic placode. EGFP reporter expression is greatly decreased in the 
otic placode of HH11-12 chicken embryos when mutating either SoxE (C),  Ets (E) or both 
Myb (G) binding motifs within enhancer Sox10E2 (A). Panels B, D, F, H show expression 
of the co-electroporated tracer pCI H2B-RFP to locate cells that received both tracer and 
reporter EGFP plasmid DNA. Figure B corresponds to A, D to C, F to E and H to G, 
respectively. 
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Figure 3. Simultaneous mutation of two SoxE, one Ets and two Myb identified sites 
within a much larger Sox10 genomic region delays gene expression in the forming otic 
region. A 3.5 kb Sox10 genomic fragment containing the intact Sox10E1 and the Sox10E2 
enhancer carrying mutations of the functional SoxE, Ets and Myb biding motifs, 
completely abolishes EGFP expression at HH9+ when endogenous Sox10 expression is 
first observed in the forming otic placode (A, arrows). Weak and scattered EGFP activity 
reappears around HH13 (B, arrows), when the otic vesicle begins to shape and is back to 
normal levels around HH15 (C, arrows). Panels D-F correspond to figures A-C respectively 
and show expression of the co-electroporated tracer pCI H2B-RFP. 
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Figure 4. cMyb and Ets2 are expressed in the presumptive otic area prior placode 
formation and Sox10 expression. Endogenous cMyb is expressed at HH9 in the 
presumptive otic placode region (A, arrows). By HH7 Ets2 is observed outside the neural 
plate (B, arrows) and otic placode region at HH9+ (C, C’). 
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Figure 5.  cMyb, Pea3 or Sox8 morpholino mediated knock-down dramatically 
reduces Sox10E2 regulatory activity in the otic placode. (A) FITC-labeled morpholino 
control (in red) does not affect Sox10E2 driven Cherry reporter expression (in green) in the 
otic placode of HH11-12 chicken embryos (B). Similarly Sox9 (D) or Ets2 (G) morpholino 
does not affect Sox10E2 regulatory activity (E, H) respectively. In contrast, morpholinos 
against either cMyb (J), Pea3 (M) or Sox8 (P), greatly reduce Cherry expression driven by 
the Sox10E2 enhancer (K, N, Q) respectively. Figures C, F, I, L, O and R are 
corresponding merged images of A/B, D/E, G/H, J/K, M/N and P/Q respectively. Embryos 
were electroporated on the right side only. The images were pseudo-colored using 
Photoshop. Green and red channels were inverted for consistency, indicative of reporter 
expression. 
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Figure 6. cMyb, Pea3 and Sox8 regulates the onset of Sox10 expression in the otic 
placode. FITC-labeled morpholino control (A, B) does not affect Sox10 expression in the 
otic placode at HH11 (H, b, arrow) and HH12 (I, arrow). Knocking down cMyb (C, D) 
strongly decreases Sox10 expression at HH11 (J, arrow) more than at a later HH12 (K, 
arrow) stage. Pea3 morpholino (E, F) strongly decreases Sox10 expression at both HH11 
(L, e, arrow ) and HH12 (M, arrow) stages, whereas Ets2 morpholino (G) has no effect on 
Sox10 expression, even at stage HH12 (N, arrow). Similar to cMyb and Pea3 morpholino 
perturbations, knocking down Sox8 (O, P) reduces Sox10 expression at HH12 (S, arrow) 
and HH13 (T, arrow) in the otic region. Depletion of Sox10 expression in the otic placode 
(U, arrow) is observed when cMyb, Pea3 and Sox8 are knock-down simultaneously (Q). 
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However, after simultaneous knock-down of cMyb, Pea3 and Sox8 (R), Sox10 expression 
recovers at HH13 (V, arrow).  Pax2 antibody staining (c, f) of cross-section from embryos 
treated with control (a) or Pea3 (d) morpholino respectively, demonstrate that Pea3 
morpholino does not affect the expression of Pax2 compared to Sox10 (b, e) and Pax2 
immunostained contralateral untreated side. Morpholinos were electroporated unilaterally 
on the right side.  
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C h a p t e r  4  
CMyb Regulates the Expression of the Neural Crest Specifier 
Ets1  
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Abstract 
 
Although the transcription factor cMyb has well known functions in 
hematopoiesis, little has been know about its distribution or function in the early embryo.  
Here, I show that cMyb transcripts are present in the early embryo during neurulation, as 
the neural folds are elevating, suggesting it may be involved in neural crest formation.  In 
avian embryos, transcript expression initiates in the neural plate border and resolves to 
the neural folds by stage HH7-8.  Expression is maintained in early migrating neural crest 
cells.  Morpholino-mediated knock-down of cMyb has differential and specific effects on 
neural crest specifier genes.  Most notably, loss of cMyb completely eliminates Ets1 
expression.  Lesser effects were noted on Snail2 and Sox10 expression, with little or not 
effect on FoxD3 or Sox9.  These results show that cMyb is an early neural crest specifier 
gene that acts upstream of Ets1.    
 
 
Introduction 
 
In avian embryos, formation of the neural crest begins at the neural plate border 
during gastrulation stages (Basch et al., 2006), and appears to involve a sequential series 
of gene regulatory interactions.  These begin by inductive signals like BMPs and Wnts 
that set up a domain at the neural plate border that expresses markers like Msx genes, 
Pax7 and Zic1, that render the border distinct from neural plate and non-neural ectoderm.  
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Some time later, neural crest cells first become identifiable as a discrete population of 
premigratory cells within the dorsal neural tube, as they express a combination of neural 
crest specifier genes such as Slug/Snail2, FoxD3, and SoxE genes. However, little is 
known about events that occur between establishment of the neural plate border and the 
appearance of bona fide neural crest cells.   
Neural crest cells share many transcription factors utilized in development of 
other stem cell populations. cMyb has important functions in a variety of developmental 
systems. Its role has been best studied during hematopoeisis, where it maintains T cells 
and other progenitors in a proliferating and immature state (Allen et al. 1999). Over-
expression of cMyb in the trunk neural tube upregulates Msx1 and Snail2, interpreted as 
evidence that cMyb may participate in BMP4 signaling input into the epithelial-
mesenchymal transition of trunk neural crest (Karafiat et al. 2005). Interestingly, cMyb 
has been shown to have later effects on differentiation of neural crest derivatives.  For 
example, it appears to influence melanocyte fate by regulating c-kit (Karafiat et al. 2007).  
Because many transcription factors are used reiteratively during development, we sought 
to examine the early expression and function of cMyb, using the early chick embryo as a 
model.   
 
Results and Discussion 
 
Isolation of full-length chick cMyb 
As a first step in understanding the possible early functions of this gene in 
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embryonic patterning, the chick homologue of cMyb was isolated and its expression from 
gastrulation through early stages of nervous system development was examined in the 
chick.  The full-length chick homologue of cMyb was obtained by a degenerate RT-PCR 
approach.   
 
Expression pattern of cMyb in the early chick embryo during neural crest formation 
The spatiotemporal expression pattern of chick cMyb was studied by whole mount 
in situ hybridization as the neural plate transforms and closes to form the central nervous 
system.  The chick develops in an anterior to posterior progression, such that the neural 
folds first elevate and close in the presumptive head region and then closure moves 
progressively tailward. Using in situ hybridization, I find that cMyb is first expressed at 
HH6 in the neural plate border. As the cranial neural folds begin elevating at HH7 (Fig. 
1A), highest cMyb expression is observed in the neural folds. As the cranial neural tube 
closes at HH8, cMyb expression remains in the presumptive neural crest region (Fig. 1B).  
Highest expression is observed at the dorsal margins of the closed neural tube, containing 
neural crest precursors, as seen in transverse section (Fig. 1E). At HH10, transcripts are 
seen in neural crest cells delaminating and emigrating from the cranial neural tube (Fig. 
1C, F). At the caudal end of the embryo in the trunk region, the neural plate is still open; 
high expression is seen in the neural plate border and elevating neural folds, similar to 
expression in the trunk.  Thus, cMyb is expressed early at the neural plate border and in 
presumptive as well as newly migrating neural crest cells.  
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Effects of cMyb knock-down on neural crest specifier gene expression 
Since cMyb is expressed in the neural plate border and forming neural folds, I 
tested the effects of cMyb loss-of-function.  To this end, I perturbed cMyb protein 
production by unilaterally electroporating FITC-tagged antisense morpholino 
oligonucleotide into one side of HH4 embryo.  Embryos were allowed to develop until 
HH8 and the subsequent effect on expression of the neural crest markers Sox9, FoxD3, 
Snail2/Slug and Ets1 was assayed.  
The results show that knock-down of cMyb (Fig. 2D) completely abolished 
expression of Ets1 (Fig. 2H; 5/5).  Effects on Snail2 expression were less severe (Figs. 
2C, G; 3/3), with expression levels about half that seen on the contralateral side.  In 
contrast, no changes were observed in expression of either Sox9 (Figs2A,E; 3/3) or 
FoxD3 (Figs. 2B, F; 3/3).  Control morpholino injected embryos also had no changes 
between the electroporated and non-electroporated side.   
This data shows that knock-down of cMyb causes selective down-regulation of 
other neural crest specifier genes.  Most notably, there was complete elimination of Ets1 
expression within the neural crest territory. An intriguing possibility is that the main role 
of cMyb may be to first induce and then maintain Ets1 expression levels, which in turn 
may act cooperatively to influence later neural crest specifier genes.  
 
Material and Methods 
 
In situ hybridization 
Sox9 probes were prepared using full length cDNA constructs (a gift from Yi-
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Chuan Cheng) as a template. Other digoxigenin-labeled antisense RNA probes, were 
prepared from chicken EST clones obtained from (ARK Genomics and MRC 
geneservice). All antisense RNA probes was synthesized using T3 RNA polymerase, 
according to standard protocols. Whole-mount in situ hybridizations were performed 
using a procedure previously described (Wilkinson 1992). 
 
Embryo culture and electroporation 
Fertilized chicken eggs were obtained from AA Laboratories, Westminster, CA 
and Chino Valley Ranchers, Arcadia, CA and incubated at 38oC for approximately 24 
hours to reach stage HH8-9. The embryos were staged according to Hamburger and 
Hamilton (Hamburger and Hamilton 1992). 
Chicken embryos were electroporated at stages HH4 to target the cranial neural 
crest cell population.  Morpholinos were introduced unilaterally to cover one side of the 
epiblast of the early chicken embryo (right to the primitive streak).  The final molar 
concentration of each morpholino oligonucleotide used was 3 mM.  
 
Morpholinos 
To target the translation initiation site, FITC-labelled morpholino antisense 
oligonucleotides or controls (Gene Tools, Philomath, OR, USA) were designed following 
general manufacturer’s instructions as follows:  
cMyb_5’-ATGGCCGCGAGCTCCGCGTGCAGAT-3’;  
Control_5’-ATGGCCTCGGAGCTGGAGAGCCTCA-3’. 
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Microscopy and inmunohistochemistry 
The electroporated embryos were collected at stages HH8-9, fixed in 4% 
paraformaldehyde overnight and then washed three times in PBS at room temperature. A 
Zeiss Axioskop2 Plus fluorescence microscope equipped with the AxioVision software 
was employed to image the embryos. Images were processed using Adobe Photoshop 
CS2. After imaging, embryos were cryo-protected in two steps: 15% sucrose/PBS and 
7.5% gelatin/15% sucrose/PBS, equilibrated and mounted in 20% gelatin/PBS and frozen 
in liquid nitrogen. 12µm cryosections were collected on Super Frost Plus slides (Fischer 
Scientific, Pittsburgh, PA) and de-gelatinized for 2 x 10 minutes at 42°C in PBS. Sections 
were subsequently washed, cover slipped and imaged using the same imaging procedure 
described for the whole-mounts.  
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Figure 1. cMyb pattern of expression in the presumptive neural crest territory. At 
HH7, cMyb is expressed within the raising neural plate folds (A) and confined to dorsal 
neural folds containing CNC by HH8 (B, section at dotted line E, arrowheads). At HH10, 
cMyb is observed in migrating neural crest (C, section at dotted line F, arrowheads). 
 
 
124 
 
           
 
 
 
Figure 2. Effects of cMyb mediated knock-down morpholino on neural crest specifier 
genes at HH8 chicken embryonic stage. FITC- labeled morpholino cMyb (A, B) does not 
affect the expression of Sox9 (E) or FoxD3 (F). In contrast, knocking down cMyb (C, D) 
slightly reduces Snail2/Slug (G) and completely abolishes Ets1 (H) expression. 
Morpholinos were electroporated unilaterally on the right side. 
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C h a p t e r  5  
CONCLUSIONS 
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My thesis project has involved the interrogation and expansion of the neural crest 
gene regulatory network by dissecting Sox10E2, the earliest acting cis-regulatory region of 
a well-known neural crest specifier gene, Sox10.  The goal was to identify direct inputs that 
initially activate its expression. This analysis has provided a framework for identifying new 
regulators and direct transcriptional linkages mediating neural crest formation. 
Interestingly, the same regulatory region also mediates initial activation of Sox10 in otic 
placode cells. Using this enhancer, I identified three Sox10 key activators, cMyb, Sox8 and 
Pea3, that appear to mediate otic expression, thus establishing new regulatory connections 
to Sox10 during ear development. 
 
A downstream Sox10 cis-regulatory module activates gene expression specifically in 
early migrating cranial neural crest and otic placode cells 
Comparative genomic analysis among seven species allowed the identification of 
seven conserved putative regulatory regions. Of those, Sox10L8 and Sox10E elements both 
regulated expression in neural crest and the otic region, though the former only in later, 
migrating crest cell populations and the forming otic vesicle. These elements controlling 
expression in late migrating neural crest, corresponding derivatives and the otic vesicle 
were similar to previously identified enhancers in mouse (Werner et al. 2007) (see Tables 1 
and 2). Five other putative regulatory regions showed no regulatory activity at the stages 
tested in vivo, but may function at later times, different cell types or may contain isolated 
negative regulatory motifs that repress Sox10 expression. 
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Dissection of Sox10E revealed a 264bp downstream regulatory region, Sox10E2, 
sufficient to regulate expression of Sox10 at early phases of neural crest cell emigration and 
during early otic placode formation, thus mimicking the onset of Sox10 expression. Further 
reduction of this fragment eliminated or largely diminished reporter expression in neural 
crest as well as otic placode cells, suggesting that Sox10E2 contains the minimal elements 
required for Sox10 regulation in both populations. This minimal enhancer consists of an 
essential core element controlling specific spatiotemporal reporter expression and 
additional auxiliary regions that enhance activity. Thus, Sox10E2 represents the first early 
neural crest and otic placode cis-regulatory module responsible for the onset of Sox10 
expression in vertebrates.  Recently, a conserved intronic regulatory region, that has no 
aparent homology to Sox10E2, has been shown to drive Sox10 expression in neural crest 
and crest derivatives in zebrafish, but not in delaminating cranial crest (Dutton J. R. et al. 
2008).   
 
SoxE, Ets, and Myb binding motifs are necessary for Sox10E2 regulatory function 
Putative binding motifs inside the Sox10E2 regulatory region were identified based 
on their position weight matrix (Hollenhorst et al. 2007) to determine the probability of 
binding score.  In silico analysis was combined with in vivo perturbations by mutating 
predicted binding motifs, as well as other conserved sequences, to test their functional 
relevance. Through these combined approaches, I identified two functional SoxE sites and 
one Ets site in the essential core portion, individual mutation of which completely 
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eliminated reporter expression in neural crest cells while strongly reducing enhancer 
activity in otic placode cells.  Simultaneous perturbation of two Myb binding sites also 
eliminated Sox10E2 reporter expression in neural crest and dramatically reduced reporter 
expression in the otic placode. Interestingly, while the function of each SoxE, Ets and both 
Myb binding motifs is required for the strong activity of the enhancer Sox10E2 in neural 
crest, the combination of all five binding motifs is necessary for the initial gene expression 
in placode cells. Thus, regulation of Sox10E2 is somewhat different for mediating Sox10 
expression in each cell population. 
Intriguingly, it appears that the role of the Myb motifs and corresponding binding 
factors may vary from species to species. Whereas in Xenopus cMyb is expressed by neural 
crest cell progenitors (Amaravadi and King 1994), similar expression has not been reported 
in the mouse (Sitzmann et al. 1995) and cMyb mutant mice have no apparent neural crest 
defects (Mucenski et al. 1991). Far less is known about cMyb expression in the otic 
placode region of other species. Comparative analysis between chicken and mammals show 
that while SoxE and Ets binding motifs within Sox10E2 share 100% conservation, one of 
the Myb motifs does not align and the other is only 75% similar to corresponding 
sequences in the mouse. Thus, a new functional Myb site in chick Sox10E2 or evolutionary 
loss of one Myb motif from the partially homologous mouse regulatory region may account 
for observed species differences (Werner et al. 2007). Alternatively, the lack of apparent 
neural crest defects in the cMyb mutant mice may be due to other compensating regulatory 
factors.  
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cMyb, Sox9 and Ets1 are upstream of Sox10 during neural crest specification 
My results show that cMyb is present at the neural plate border at stage HH6 and 
persists in premigratory crest in the dorsal neural folds, therefore preceding Sox10. The 
finding that mutation of two Myb sites in the Sox10E2 element abolishes reporter 
expression together with the cMyb loss-of-function experiments show that it is required for 
Sox10 expression. Thus, illuminating a new role for cMyb in the gene regulatory network 
controlling neural crest cell specification. Recently, cMyb was shown to specify 
melanocyte fate by regulating c-kit (Karafiat et al. 2007), suggesting it acts within the 
neural crest specifier module. Its presence at the neural plate border suggests early 
involvement in the NC-GRN, concomitant with early neural crest specifiers such as AP-2, 
c-Myc or Snail2. Furthermore, overexpression of cMyb upregulates Msx1 and Snail2, 
interpreted as evidence that cMyb may participate in BMP4 signaling input into the 
epithelial-mesenchymal transition of trunk neural crest (Karafiat et al. 2005). 
Although several lines of experiments suggest that Sox9 can regulate Sox10  
expression, it is not clear wether Sox9 directly regulates the onset or maintenance of Sox10. 
Sox9 expression precedes that of Sox10 in all vertebrates examined (Hong and Saint-
Jeannet 2005).  Knock-down of Sox9 in Xenopus neural crest precursors depletes Sox10 
expression (Lee Y. H. et al. 2004b), whereas chick Sox9 misexpression induces ectopic 
Sox10 in the trunk neural tube (Cheung and Briscoe 2003).  In Sox9 mutant mice, Sox10 
persists in early migrating trunk neural crest cells but is absent in neural crest derivatives 
(Cheung et al. 2005). Recently EMSA assays demonstrate that Sox9 and Sox10 proteins 
can bind to SoxE binding motifs within different mouse Sox10 regulatory regions in vitro 
(Werner et al. 2007).  
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Finally, expression of a third putative upstream regulator, Ets1, precedes that of 
Sox10 at cranial levels, but is absent in trunk neural crest progenitors (Tahtakran and 
Selleck 2003). Ets1 plays a role in cranial neural crest delamination and appears to 
mitigate the requirement for S phase synchronization to promote neural crest emigration 
in a cluster-like fashion (Theveneau et al. 2007). In contrast, trunk neural crest cells 
undergo cell-cycle arrest prior to delamination, dividing only once out of the neural tube 
(Burstyn-Cohen and Kalcheim 2002). Accordingly, ectopic expression of Ets1 in the 
trunk results in excess, cluster-like emigration of Sox10-expressing cells (Theveneau et 
al. 2007).  Interestingly, ectopic expression of the Sox10E2 reporter in the trunk neural 
tube was observed when Ets1 is overexpressed (effect not observed when over 
expressiong either cMyb or Sox9, which are normally present in this location) (Cheung 
and Briscoe 2003, McKeown et al. 2005, Tahtakran and Selleck 2003, Theveneau et al. 
2007). Thus addition of Ets1 may be sufficient to activate Sox10E2 reporter expression 
where it is normally lacking, raising the intriguing possibility that the newly identified 
Sox10E2 regulatory element may act as a switch between head and trunk neural crest 
populations, accounting for the morphological differences in delaminating cranial 
(clustered) versus trunk (individual cell-cycle arrested) crest.  
Furthermore, co-expression of Sox10E2 reporter construct with Sox9, Ets1 or 
cMyb results in ectopic enhancer activation in the extraembryonic region. 
Extraembryonic regions retain regulatory factors characteristic of multipotent tissue, and 
often are considered “naïve” (Streit and Stern 2008, Streit et al. 1997). Thus, these cells 
retain competence to respond to multiple inducing signals and may possess intrinsic 
signals that, together with an added specific factor, ectopically activate the Sox10E2 
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enhancer. One possibility is that this occurs indirectly, such that each factor can induce a 
neural crest like transcriptional program including the induction of a complete suite of 
factors necessary for Sox10E2 activity. Alternatively, repressors that suppress module 
activity may be present in other locations. As case in point, the element controlling down  
regulation of endogenous Sox10 expression within the branchial arches appears to be 
missing in the 3.5 kb Sox10E construct such that Sox10E2 and 10E1 enhancers activate 
reporter expression the first two, and last three arches, respectively.  
 
Ets1, Sox9 and cMyb directly bind to Sox10E2 enhancer in vivo and are necessary for 
regulation of Sox10 expression in neural crest cells 
Endogenous cMyb, Sox9 or Ets1 factors are necessary for Sox10E2 enhancing 
activity in the cranial neural crest. Inactivation of these upstream regulators, together with 
mutation of their binding motifs and chromatin immunoprecipitation, clearly demonstrate 
that Ets1, Sox9 and cMyb converge onto the Sox10E2 cis-regulatory element and directly 
regulate onset of Sox10 expression in delaminating neural crest cells. Morpholino-
mediated inactivation of individual upstream regulators completely abolishes Sox10E2 
reporter activity, while greatly reducing endogenous Sox10 expression. Importantly, 
simultaneous inactivation of all three factors leads to a complete loss of initial Sox10 
expression (at HH8+) indicating that Sox9, cMyb and Ets1 transcription factors are 
responsible for initial activation of Sox10 expression in cranial neural crest. Later, 
activation of different regulatory elements likely activates and maintains Sox10 
expression in migrating neural crest. The direct binding of cMyb, Sox9 and Ets1 to the 
Sox10E2 element, shown by chromatin immunoprecipitation, gel shift assays, combined 
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with mutational analysis of their binding sites within not only the enhancer but also a 
much larger genomic region, indicate that these factors directly control the onset of Sox10 
expression in the cranial neural crest via the core regulatory element Sox10E2.  
 
cMyb regulates Ets1 expression during NCC specification 
Knock-down of cMyb not only affects Sox10 expression, but also causes down-
regulation of other neural crest specifier genes.  Most notably, there was complete 
elimination of Ets1 expression within the neural crest territory. An intriguing possibility is 
that cMyb first induces Ets1 and together they act to directly activate Sox10.  A regulatory 
battery of similar dynamics is used during melanocyte differentiation, where Sox10, in 
addition to directly regulating the expression of microphthalmia-associated transcription 
factor (Mitf), acts synergistically with Mitf to directly control the expression of 
dopachrome tautomerase (Dct/Trp2) (Sauka-Spengler and Bronner-Fraser 2008a).   
 
cMyb in combination with Sox8 and Pea3  activate Sox10 gene expression in otic 
placode 
In the otic placode, however, the onset of Sox10 expression through Sox10E2 is 
mediated by cMyb in combination with Sox8 and Pea3. Whereas regulation of Sox10 in 
neural crest cell individually requires each of the Sox10 activators, cMyb, Sox9 and Ets1, 
elimination of individual factors in the otic placode reduces but fails to eliminate Sox10E2 
activity or Sox10 endogenous expression. However, simultaneous depletion of the three 
factors completely abolishes sox10 endogenous expression during otic placode 
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development; and later Sox10 expression appears to recover, when the otic vesicle begins 
to shape, probably mediated by other Sox10 cis-regulatory regions with different inputs.  It 
is not yet know if the onset of Sox10 expression is controlled directly by the binding of 
Sox8 and Pea3 to the corresponding SoxE and Ets binding motifs within Sox10E2 
enhancer. Future experiments will utilize chromatin immunoprecipitations and gel shifts to 
test for direct binding similar to what has been done for cMyb, Sox9 and Ets1 with 
Sox10E2 in neural crest cells.  Ets1 and Pea3 are both known to recognize the same Ets 
binding motifs (Fisher et al. 1991). Moreoever, both Ets1 or Pea3 can regulate expression 
of the TGF-beta receptor (TbetaR-II) gene through the same enhancer, as demonstrated in 
embryonal carcinoma cells (Kopp et al. 2004). This suggests that Ets1 and Pea3 may 
activate Sox10 expression, through the shared Ets functional binding motif within the 
enhancer Sox10E2. Similarly, there is evidence that Sox9 and Sox10 can share the same 
binding motifs within other Sox10 regulatory regions in mouse (Werner et al. 2007). Thus, 
it seems likely that Sox8 has the ability to bind to SoxE binding sites within the Sox10E2 
enhancer.  
In summary, in-depth interrogation of the newly identified Sox10E2 regulatory 
module has allowed identification of two new neural crest specifier, cMyb and Ets1 that are 
involved in regulating early gene expression in the neural crest cells.  Together with Sox9, 
Ets1 and cMyb converge onto and directly bind to the Sox10E2 enhancer to regulate 
reporter and endogenous Sox10 expression in the cranial neural crest. Interestingly, cMyb, 
Sox8 and Pea3 activate this same enhancer in the otic placode. Such identification and 
perturbation of regulatory sequences and the candidate upstream regulators controlling 
them provides a powerful tool for demonstrating direct binding interactions and testing 
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regulatory outcomes in vivo.  Our analysis of novel regulatory regions provides new 
information that has expanded our knowledge of the gene regulatory interactions that occur 
during formation of both the vertebrate neural crest and developing ear. 
 
 Possible conserved role for the SoxE group of transcription factors in neural crest cells 
and otic placode during evolution 
Previous studies have shown that Sox8, Sox9 and Sox10  genes, belonging to the 
SoxE family of transcription factors are expressed by both neural crest and otic placode 
cells across different vertebrate taxa. However, the timing of the onset of expression for 
different SoxE paralogs in the two populations varies across species. For instance while in 
Xenopus neural crest progenitors Sox8 expression is followed by Sox9 and Sox10, in 
chicken neural crest, Sox9 is the first SoxE factor to appear closely followed by Sox8 and 
Sox10 (Hong and Saint-Jeannet 2005). Conversely, in the otic region of the chicken 
embryo, Sox9 is expressed only later, in the formed vesicle, whereas the early forming 
territory is marked first by Sox8 and then by Sox10 expression. Despite different paralogue 
usage across species, the shared expression of SoxE genes in both neural crest and otic 
placodes is a common feature of vertebrates.  It is even conserved in the basal vertebrates, 
such as lamprey, where SoxE3 expression resembles that of Sox10 and SoxE2 is similar to 
that of Sox9 (Fig. 1). Intriguingly, my thesis work shows that the onset of Sox10 expression 
is regulated by one common neural crest and otic placode enhancer. Similarly, other Sox10 
enhancers characterized in mouse and zebrafish, display activity in both population of cells 
as well (Tables 1 and 2 detail the chicken Sox10 enhancers activity compared to Sox10 
enhancers identified in other species). Such enhancers with a dual function in neural crest 
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and otic placode have also been previously shown to control Sox9 expression in mouse. 
Bagheri-Fam and colleagues showed that enhancer E3 regulates weak initial expression of 
Sox9 in cranial neural crest cells and otic placode as early as 8.5 dpc, when initial 
endogenous Sox9 expression is first observed. Altogether, this information, may suggest a 
close evolutionary connection between neural crest cells and otic placode cells, marked 
firstly, by the required expression of the SoxE family of genes in both population of cells 
and secondly by the utilization of the same enhancers to activate and maintain SoxE 
expression uniquely in both populations of cells. While the requirement for SoxE function 
in both neural crest and placodal populations is indicative of a common cellular function, 
the reiterative use of a single cis-regulatory element to regulate gene expression in both cell 
populations could reflect a common evolutionary origin. In the case of chick neural crest 
and otic development, it appears that the Sox10 and Sox9 enhancers have retained their 
ability to respond in two different cellular environments with little or no rearrangement at 
the cis-regulatory level.  
A common neural crest and placode evolutionary origin has been proposed before 
based on fate maps drawn from zebrafish, Xenopus, mouse and chicken that show that 
during gastrulation the ectoderm is subdivided into neural and non-neural ectoderm and, 
within the intermediate region where both overlap (Fernandez-Garre et al. 2002, Garcia-
Martinez et al. 1993, Keller 1975, 1976, Kimmel et al. 1990, Tam 1989), precursors for 
different placodes including otic are still widely dispersed and intermingled with future 
neural crest, neural and epidermal cells (Garcia-Martinez et al. 1993, Hatada and Stern 
1994). At early neurula stage a contiguous stripe of ectoderm (termed the neural plate 
border) co-expresses pre-neural and non-neural ectoderm markers.  Within the border 
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region, precursors for neural, neural crest, epidermis and placodes remain interspersed 
(Streit 2002). Thus in this region, similar sets of inductive signals affect the cell fate 
specification of neural crest vs placode cells, and both populations are exposed to FGF8, 
BMPs and Wnts, which establish the neural plate border. However, in the chicken embryo, 
the underlying future heart mesoderm secretes BMP and Wnt antagonizers. As this 
signaling source is in proximity to placodal precursors within the border, it has been 
proposed that these antagonizers protect future placode cells from Wnt and BMP 
influences, thought to induce neural crest or epidermis progenitors. It is plausible that in a 
hypothetical vertebrate ancestor both cell populations could have been exposed to the same 
inductive signals. Subsequent evolutionary changes to the neighboring environment may 
have then rendered one cell subpopulation, in this case placodal cells, responsive to new 
signals secreted by newly adjacent regions. The signaling switch would have resulted in 
upregulation of different, possibly novel combinations of regulatory factors, creating a 
different transcriptional output and ultimately changing the fate of the cell. Such changes 
likely intervene at the cis-regulatory level by turning on new modules and turning off or 
changing the response of existing active elements. This could explain why the Sox10E2 
regulatory region, responsible for the onset of Sox10 in neural crest cells, responds to 
cMyb, Sox9 and Ets1 inputs, while in otic placode cells it is activated by a combination of 
cMyb with different SoxE and Ets paralogs, Sox8 and pea3. The new combination of 
regulatory factors upregulates Sox10 in the otic placode cells, which otherwise present 
many characteristics distinguishing them from neural crest.  
A hypothesis proposing a common neural crest and placode origin would agree 
with Gans and Northcutt’s idea that vertebrate-specific characters arose mainly from neural 
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crest and cranial placode cells, providing respective derivatives with adaptations for a 
mobile predatory life style (Baker 2008, Northcutt and Gans 1983). They also argued that 
the chordate common ancestor probably had a neural crest/placode precursor involved in 
sensory tissue development. This precursor would have been part of a diffuse ectodermal 
nerve plexus, such as that seen in some modern deuterostomes, including echinoderms and 
hemichordates and did not form condensations characteristic of vertebrate placodes. 
Evidence for this has come from analysis of ascidians and cephalochordate molecular 
embryology (Baker and Bronner-Fraser 1997). The ascidian neurohypophyseal duct that 
connects the cerebral ganglion to the oral cavity is neurogenic and produces migratory 
cells. Thus, it has been proposed as a good candidate homolog for both neural crest and for 
the combined olfactory and adenohypophyseal placodes (Burighel et al. 2003, Manni et al. 
2004).  
Alternatively, it is possible that the neuroepithelial layer, containing neural crest 
and placode progeny, coopted similar gene batteries and then each population evolved 
independently influenced by their environments, which in turn created differential 
expression of paralog genes. For instance, in the most basal chordate, Amphioxus (a 
cephalochordate), most neural plate border specifiers are found in the neural plate border 
while most neural crest specifiers, with the exception of SoxE found in the neural tube, are 
expressed in the underlying mesoderm (Baker 2008, Meulemans and Bronner-Fraser 2005, 
2007). It is possible that “the neural crest specifier genes” were recruited by some cells in 
the neuroepithelial domain (future neural crest), while SoxE was coopted simultaneously by 
presumptive neural crest and otic placode cells found in the same domain. 
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The possible common origin of the neural crest and placode cells is a subject of 
great controversy. First, there is no fossil record of an ancestral organism that suggests 
such a common origin. Also it should be considered that while the Sox10E2 neural crest 
and otic placode conserved enhancer is highly conserved across amniotes, it has not been 
found to be conserved to anamniotes, perhaps because the location in the genome has 
been changed and yet, genomic comparisons have not been done to more basal 
vertebrates, such as lamprey. Identifying a conserved region that is equivalent to 
Sox10E2 in these species will give more insight regarding the conserved function of this 
enhancer in neural crest and placode cells. In addition, it is important to bear in mind that 
such regions may never be found if the same comparative protocols used to search for 
conserved regions are applied. Due to evolutionary distance, many non-essential regions 
may have been added or lost. Moreover, while the essential functional motifs have been 
conserved, changing distances between and/or order motifs, may make it difficult to 
recognize conserved regions.   
Further data arguing against the common-origin hypothesis comes from single 
cell labeling experiments which strongly indicate that neural crest and placode cells at the 
neural plate territory are not a mixed population but are already preprogrammed to adopt 
one of the fates (Selleck and Bronner-Fraser 1995). Finally, to date there is no evidence 
of molecular factors that are exclusively expressed by neural crest and placode cells at the 
border territory.  Markers that are expressed by both cell populations are expressed 
broadly and are also found in the neural plate or non-neural ectoderm future epidermis. 
Interestingly, the one exemptions is members of the SoxE family, although not expressed 
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when both populations of cells are intermingling at the neural plate border, but later when 
neural crest cells are localized in the dorsal folds of the neural tube and the otic placode 
cells are located outside the neural domain.  
Rather than supporting the hypothesis of a common evolutionary origin of neural 
crest and placodes, it has been strongly suggested that all placodal populations come from a 
single preplacodal cell state. This implies that in an ancestral organism, primitive neural 
crest cells were a separate entity from primitive placode cells (Schlosser 2008). This is 
supported by the expression pattern of certain genes like Eya and Six family members, 
which are expressed uniquely by all placodal progenitors (Streit 2007). A further argument 
supporting the common preplacode origin are based on otic induction experiments in 
chicken, which demonstrate that when explanted and exposed to an environment that can 
induce a preplacodal state (FGF signal), cells with epidermal fate can express otic placode 
markers. If the presumptive epidermal cells do not acquire a preplacodal state first, they fail 
to express otic markers (Martin and Groves 2006). These experiments suggest a common 
specification mechanism for all placodal populations, but, it does not address their possible 
common evolutionary origin. Thus, the possibility of a common evolutionary origin of 
placodes and neural crest remains an open argument.  
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Figure 1. SoxE3 and E2 in lamprey are concomitantly expressed by neural crest and 
otic placode cells. (A) The Pattern of expression of lamprey SoxE3 is similar to that of 
Sox10 in other vertebrate embryos. Expression is observed in migrating cranial neural crest 
and in the otic placode. Expression of SoxE2 resembles early expression of Sox9 in other 
vertebrates. When neural crest cells have begun migration, no SoxE2 expression is 
observed in the otic placode (B). Later on, when neural crest cells are extensively 
migrating, SoxE2 expression appears in the otic as it shapes into a vesicle (C).  
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Table 1. Sumary of Sox10 enhancers activity at the cranial level and ectopic areas 
 
++ Strong activity 
+ weak activity 
- No activity 
CRE Cis-regulatory element 
OP Otic placode 
OV Otic vesicle 
CNCC Cranial neural crest cells 
BA Branchial arches 
BV Blood vessels 
H Heart 
DSC Dorsal spinal cord 
NT Neural tube 
CS Craniofacial skeleton 
 
For E1 and D6 (in blue), E2 and D7 (in green), L8 and U3 (in purple) the enhancers have 
equivalent sequences.  
 
 
 
 
 CRE Size 
bp 
Delaminating 
CNCC 
OP Migrating 
CNCC 
Cranial 
ganglia 
OV Ectopic 
Chick E1 600 - - - + + - 
Mouse D6 229    ++ ++ - 
Chick E2 264 ++ ++ ++ ++ ++ ++ (BA) 
Mouse D7 235    - - - 
Chick L8 3000 - - +  +  
Mouse U3 396    ++ - + (H & 
DSC) 
Mouse U1 190    ++ ++ - 
 U2 190    ++ - - 
 U4 149    - - + (BV) 
 U5 170    ++ - - 
 MCS3 759    - -  
 MCS8 667    ++ + + (CS) 
 MCS9 665    ++ -  
Zebra- 
fish 
pSox10 
1252D(
+159 
+1862) 
> 
1000 
- ++ + + ++ + (NT) 
Xeno-
pus 
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 CRE Size 
bp 
 
Delaminating 
V&T NCC 
Migrating   
V&T 
NCC 
DRG ENS AG Melanocytes 
Chick E1 600 - + +    
Mouse D6 229   + - - - 
Chick E2 264 - - -    
Mouse D7 235   - - - - 
Chick L8 3000       
Mouse U3 396   - + - + 
Mouse U1 190   + + + - 
 U2 190   + - - - 
 U4 149   - - - - 
 U5 170   + - - - 
         
 MCS3 759   - -  - 
 MCS8 667   - +  - 
 MCS9 665   - -  + 
Zebra- 
fish 
pSox10 
1252D(
+159 
+1862) 
> 
1000 
+ + +   - 
Xenopus         
 
Table 2. Summary of Sox10 enhancers activity at vagal and trunk level 
 
++ Strong activity 
+ weak activity 
- No activity 
CRE Cis-regulatory element 
V&T NCC Vagal and trunk neural crest cells 
DRG Dorsal root ganglia 
ENS Enteric nervous system 
AG Adrenal gland 
 
For E1 and D6 (in blue), E2 and D7 (in green), L8 and U3 (in purple) the enhancers have 
equivalent sequences. 
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